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ABSTRACT 
Purpose: Assessment of health technologies in medical practice is an ongoing 
process to provide clinicians and policymakers with information on the value of those 
applications. This dissertation aims to add to the existing body of literature and fill the 
gaps in prior studies by assessing two health technologies in Mayo Clinic Florida (MCF). 
The first paper provides an assessment of patient portal adoption and activity during 
hospitalization among cancer patients, and determines whether a portal application is 
associated with selected indices of patient safety, utilization and satisfaction. The second 
paper provides an assessment of a new approach in pain management after total knee 
arthroplasty (TKA), a periarticular anesthetic injection (PAI), and compares patient 
outcomes postoperatively among those who had this new pain management approach 
versus the traditionally used approach of peripheral nerve blocks in a consecutive earlier 
period.  Methods: The first paper retrospectively reviewed all cancer inpatients admitted 
in MCF between 2012-2014 (N=4,594), compared portal adopters (i.e., who registered 
for a portal account) versus non-adopters, and compared inpatient portal activity among 
active versus inactive users. The second paper retrospectively reviewed consecutive 
patients who underwent primary unilateral TKA between March 1, 2013, and August 31, 
2014 (N=511) and received FNB with SNB versus those who underwent TKA between 
October 1, 2014 and March 31, 2016 (N=479) and received PAI. In addition to 
descriptive statistics, postoperative outcomes, including pain scores, time to ambulation, 
distance walked, in-hospital falls, length of stay, discharge disposition, satisfaction wit
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pain control, emergency visits within 14 days, readmissions within 30 days, revisions 
within 90 days, and total cost of hospitalization and 90-day follow-up period, were 
compared. SAS Version 9.4 was used for all analyses.  Results: We found that 2352 
(51.1%) were portal adopters, and of them, 632 (26.8%) were active inpatient users. 
Adoption was influenced by predisposing and enabling factors, such as age, sex, race, 
marital status, employment status, income, and type of health insurance. Active inpatient 
use was similarly influenced by predisposing and enabling factors, such as age, race, and 
marital status, in addition to factors related to need, such as being sicker, nonlocal and 
admitted for medical treatment (P<0.05). In the second paper, we found that PAI had 
better analgesic effect at 24 hours after surgery compared to FNB, but no differences at 
48 hours. Patients who received PAI had earlier ambulation, longer walking distance, 
shorter hospital stay, more discharges to home, better patient satisfaction with pain 
control, and lower hospitalization cost. On average, each patient who had their pain 
managed using PAI saved $3,539 on their TKA hospitalization cost. Conclusion: Based 
on early evidence, cancer patients reached modest levels of portal adoption, with 
increased adoption associated with predisposing and enabling determinants, and 
increased inpatient use associated with need. In pain management after TKA, PAI was 
superior in providing early postoperative pain relief, improved functional recovery, better 
patient satisfaction with pain, and lower hospitalization cost compared to FNB with 
single-shot SNB following TKA. Findings may provide insight for clinicians and 
policymakers who are interested in health technology assessment and directing future 
research efforts on the value of care. 
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CHAPTER 1 
INTRODUCTION 
 
BACKGROUND 
Medical practice has made rapid advances over the years through the adoption of 
innovative clinical and information technologies which help to provide high-quality 
health care. These technologies can result in more convenient, more-effective care 
delivery and improved patient outcomes [1-3]. However, they are one of the primary 
drivers of increased healthcare costs in the United States and society expects these new 
advances to add benefits to their health outcomes [4, 5]. In fact, 17.4% of United States 
GDP is currently consumed by the health care sector, and projected to reach about 19.6% 
by 2024 [6]. The Congressional Budget Office concluded that “roughly half of the 
increase in health care spending during the past several decades was associated with 
expanded capabilities of medicine brought about by technological advances” [7].  
Although healthcare technology continues to advance remarkably, its assessment 
continues to lag significantly [8]. This assessment function requires collecting, 
evaluating, and systematically reviewing all available evidence related to the use of the 
technology under consideration. The Institute of Medicine reported that the cost of 
healthcare assessment is less than 0.3% of the total amount spent on healthcare [9]. 
2 
 
The Office of Technology Assessment was established in 1972 and was funded by 
the US Congress to undertake technology assessments to inform federal funding 
decisions about emerging health and non-health technology [10]. In the 1990s, Health 
Technology Assessment (HTA) was widely used and the assessments tended to focus on 
efficacy, safety, cost-effectiveness, as well as patient-reported outcomes [10, 11]. HTA 
also have the objective of providing a basis for health care that is more evidence-based in 
order to be  use scarce resources more efficiently, and  improve health for patients and 
the general population [12].  
As defined by the United States Office for HTA, healthcare technologies include 
drugs, devices, medical and surgical procedures as well as organizational and supportive 
systems in which such care are provided [13]. In light of this definition, this dissertation 
evaluates two healthcare technologies in Mayo Clinic Florida (MCF); an electronic 
patient portal, and a new pain management approach used after total knee arthroplasty 
(TKA).  The document is presented in the following format: Chapter 1 provides basic 
background information on the problem, rationale and the research questions related to 
the two selected health applications; Chapter 2 provides an in depth review of relevant 
research and the gap in literature; Chapter 3 provides the research methodology; Chapter 
4 provides a manuscript related to patient portals; and Chapter 5 provides a manuscript 
related to pain management after TKA. Results should provide insight for clinicians, 
policymakers, research community and those interested in improving patient care through 
technology. 
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Study I: Patient Portal Adoption and Use by Hospitalized Cancer Patients: A 
Retrospective Study of its Impact on Adverse Events, Utilization, and Patient 
Satisfaction 
STATEMENT OF THE PROBLEM 
A Patient Portal tied to the provider electronic health record systems is a new 
innovation in health information technology that is gaining popularity [14]. It grants 
patients’ access to their own medical records, which is expected to transform how 
healthcare is delivered [15, 16]. Since 1996, patients could legally access their clinical 
records as part of the Health Insurance Portability and Accountability Act. However, 
fees, illegible handwriting, or time delays were barriers that hindered information access 
[17]. What sets the portal apart is the speed and flexibility with which patients can access 
their updated health information securely at any time, to view information like recent 
doctor visits, discharge summaries, medications, immunizations, allergies, and lab 
results. More advanced portals enable patients to request prescription refills, schedule 
appointments, exchange secure messaging with providers, and receive health educational 
programs.  
Most published studies about patient portals describe their use in the primary care 
or outpatient settings [15, 18, 19]. Numerous research studies have shown that 
information provided in the portal are effective in stimulating patients with chronic 
conditions to monitor their care and promote their decision-making ability [20-22]. Yet, 
few studies were found exploring portal use patterns among patients with Cancer, whom 
in critical need for additional support for health information and care [23-26]. They 
receive treatment through complex plans involving multiple care providers and settings 
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such as surgery, radiation, and chemotherapy, which make information availability a 
crucial part for them to reduce uncertainty and allow them to be responsible for making 
important decisions.  
RATIONALE FOR THE STUDY  
Portals are considered a promising innovation to support greater patient 
engagement. Patients who are engaged in their health have better adherence to safety 
practices, better compliance and partnership with the healthcare team, and may 
participate more in clinical trials and research [20, 27-29].  The Institute of Medicine 
report “Crossing the Quality Chasm” suggested that enhancing the flow of information 
among patients and medical providers would help reduce medical errors and improve the 
quality of care [30]. A study by Weingart and colleagues in ambulatory oncology found 
that active patient participation may reduce the risk of medical errors by providing 
clinicians with current information about their medical histories, medications and drug 
allergies [31]. In the inpatient setting, Weingart and colleagues surveyed 2025 patients 
and found that active patient participation was strongly associated with favorable 
judgments about hospital quality and reduced the risk of experiencing an adverse event 
[32]. Prey et al 2014 conducted a systematic review of patient engagement in the 
inpatient setting and concluded that research on inpatient engagement technologies has 
been limited [33]. Therefore, patient portals represent a significant shift in the way that 
health services are delivered and an opportunity to incorporate electronic health 
technologies into clinical practice.  
In 2009, the Health Information Technology for Economic and Clinical Health 
(HITECH) Act incentivized clinicians to provide patients’ with electronic access to 
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clinical records through the “meaningful use” incentive program administered by the 
Centers for Medicare & Medicaid Services (CMS). Stage 1 meaningful use criteria 
include providing patients with an electronic copy of their health information, whereas 
stage 2 criteria were broadened to include enabling patients to view online, download, 
and transmit information about a hospital admission. Recently, CMS published the final 
rule for Stage 3, which focuses on the advanced use of the electronic portals to promote 
health information exchange and improve patients’ outcomes [34]. Although providers 
are subject to a financial penalty if the rules are not met, they are not incentivized if they 
improve, such as by having a high rate of portal users, or providing advanced 
functionalities that offer value to providers and patients. Thereby, as a policy implication, 
policymakers should not only focus on the existence of electronic portals, but on the 
effective use to achieve better engagement, health and satisfaction.  
To this purpose, hospital leaders at MCF were interested to understand the pattern 
of portal adoption and active use behaviors, specifically to the inpatient setting where 
research is limited and the pattern in unknown. According to Karahanna et al., adoption 
and continued use of an IT innovation represent different behavioral intentions [35]. 
Adoption is the initial usage (new behavior) of an innovation, while usage is the 
subsequent continued use of an innovation after its adoption. In this study, Adoption is 
the initial enrollment and signifies receptivity to the portal, while usage represents active 
engagement, continued use after adoption. Therefore we distinguish between these two 
behaviors and evaluate them separately.  
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RESEARCH QUESTIONS: 
The study will answer the following research questions: 
1. What are the characteristics of patients who are portal adopters, non-adopters, 
active inpatient users, and inactive inpatient users? 
2. What factors influence portal adoption? What factors influence inpatient 
portal use?  
3. Compared to non-adopters, what is the association between: (a) active 
inpatient use, and (b) inactive inpatient use, with adverse events, utilization 
(14-days emergency visits, 30-days readmissions), and patient satisfaction 
(self-management knowledge, overall satisfaction)?  
Hypotheses:  
1. I hypothesize that majority of portal adopters will be those who are young, 
Caucasians, male, and married. We also hypothesize that inpatient users will be 
those who are young, married, and sicker. 
2. I hypothesize that predisposing factors (age, race, and marital status) will 
influence portal adoption, and need factors will influence active inpatient portal 
use.  
3. I hypothesize that inpatient portal use will not be significantly associated with 
reduced adverse events, emergency visits, and readmission, or improved patient 
overall satisfaction. However, portal use may have a positive association with 
self-management knowledge. 
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Study II: Combined femoral and single-shot sciatic nerve block versus periarticular 
anesthetic injection for pain management after total knee arthroplasty 
STATEMENT OF THE PROBLEM  
Pain is one of the main concerns of patients undergoing total knee arthroplasty 
[36]. Over the last decade, different pain management techniques have become broadly 
used as an alternative to opioids alone in pain management. The most common pain 
control methods in TKA are general anesthesia, regional anesthesia using neuraxial 
blockade (spinal or epidural anesthetic), and peripheral nerve blocks. However, general 
and regional anesthesia may be inadequate as it causes extended recovery room stays, 
postoperative nausea or vomiting, and associated added costs [37]. Epidural analgesia is 
of proven benefit but is associated with side effects such as spinal headache, neurogenic 
bladder, hypotension, respiratory depression, pulmonary hypertension, cardiac 
decompensation, and a risk of spinal infection [38, 39]. Continuous infusion of opioids 
and bupivacaine into the knee has provided good postoperative pain control but may be 
associated with prolonged wound drainage [40]. Recent studies on continuous femoral 
nerve blocks found it associated with higher incidence of muscle weakness and opioid 
consumption, which led to delays in patient ambulation and more falls [41-43]. Recently, 
the emergence of periarticular injections that provide effective control of postoperative 
pain with fewer side effects has been one of the most important advances in orthopedic 
surgery. In fact, adequate pain control using PAI in TKA is viewed as a revolution in the 
management of postoperative pain, and a paramount to successful outcomes and patients’ 
satisfaction [44]. Previous studies have shown that PAI are easier to administer, provide 
earlier mobilization, and are less costly [44-49]. 
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At MCF, a peripheral nerve block was the default pain control approach used in total 
knee arthroplasty, using continuous femoral nerve block with single-shot sciatic nerve 
block. As the introduction of periarticular injections become a new advancement, the 
sister site, Mayo Clinic Arizona published results of a major randomized clinical trial 
conducted between 2010 and 2013, comparing combined femoral and sciatic nerve block 
with PAI as part of a multimodal pain protocol. Results found that PAI had equivalent 
pain relief scores, but shorter lengths of stay, and fewer complications than those 
associated with peripheral nerve blocks [50]. In September 2014, surgeons in Mayo 
Clinic Florida (MCF) showed interest in pursuing a practice change, following the 
Arizona model of care for pain management. They piloted the administration of PAI to a 
couple of patients’ undergoing TKA, and preliminary results revealed superior 
improvements in patients’ postoperative pain scores and recovery. Therefore, in October 
2014, the orthopedic practice in MCF transitioned to primarily use PAI for pain 
management after TKA. Since then, the change in practice from the prior to the later pain 
management approach has not been rigorously evaluated in terms of analgesic efficacy, 
functional recovery, length of stays, patient satisfaction and total cost. Also, differences 
between these pain management approaches beyond the inpatient setting are unknown. 
We documented post-discharge measures including emergency visits (14-days), 
readmissions (30-days), revisions (90-days), and total cost incurred during the 90-day 
period.  While most published studies did report measures of pain relief and functional 
recovery, to our knowledge, this is the first study to examine detailed cost per services 
between PAI and FNB with single-shot SNB for primary TKA. 
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RATIONALE FOR THE STUDY  
There is a rapid increase in the number of TKA procedures performed annually 
[51]. In 2005, 450,000 primary knee replacements were performed and projected to 
increase almost eight-fold to 3.48 million in 2030, making joint replacements the most 
common elective surgical procedures in the coming decades [52]. Because these 
procedures are elective and expensive; Medicare paid approximately $3.2 billion in 2000 
for hip and knee joint replacements, and because the prevalence of arthritis is expected to 
grow substantially as the population ages, the demand for these procedures are likely to 
increase [53]. Thus, healthcare services delivery must be planned effectively to meet 
patients’ need and expectations for successful, safe and less painful procedures. Poorly 
managed postoperative pain can prolongs the recovery and mobilization process, delays 
discharge, reduces quality of life and increases unnecessary healthcare utilization such as 
unscheduled readmissions [54]. Proper pain management allows patients’ to ambulate 
faster, decrease their risk of having venous thromboembolism or acquiring hospital-based 
infections due to longer hospital stays, and consequently reduce cost [55-58].  
The IOM report “Across the Chasm: Six Aims for Changing the Health Care 
System” outlined the most important aims to deliver better outcomes, where care should 
be safe, effective, patient-centered, timely, efficient and equitable [30]. Fortunately, 
advanced improvements in technology through devices and innovative techniques have 
broadened the awareness in implementing best practice strategies for surgical and 
anesthetic management. In fact, the choice of pain anesthetic technique has been shown 
to play a significant role in promoting favorable surgical outcomes. Yet, few evaluation 
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studies focused on evaluating TKA outcomes associated with using nerve blocks or 
periarticular injections in light of these specific IOM aims.  
The primary aim of this study was to compare patient outcomes postoperatively in 
two exclusive, yet consecutive periods; a period where peripheral nerve blocks were used 
versus the use of a periarticular anesthetic injection of ropivacaine, epinephrine, 
ketorolac, and morphine, for pain management after TKA. Given the high frequency of 
this procedure, results of this study may provide insight for clinicians to determine 
efficient pain management approaches after TKA, and promote evidence-based clinical 
policy for cost-effective pain management in orthopedic care. Results will also be useful 
for patients to take an active role in their care and make more informed decisions 
regarding their pain management approach.  
RESEARCH QUESTIONS: 
This study will answer the following research questions: 
1. Are there significant differences in hospital outcomes of TKA patients who 
received FNB versus PAI for pain management in terms of: (1) pain scores at 24 
hours and at 48 hours, (2) time to first ambulation, (3) distance walked, (4) in-
hospital falls, (5) length of hospital stay, (6) discharge disposition, and (7) total 
hospitalization cost? 
2. Are there significant differences in post-discharge outcomes of TKA patients 
who received FNB versus PAI for pain management in terms of: (1) patient 
satisfaction, (2) emergency department visits within 14-days, (3) unplanned 
readmissions within 30-days, (4) revisions within 90-days, and (5) total cost of 
90-day post-discharge period? 
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Hypotheses: 
1. I hypothesize that patients’ who received PAI compared to nerve blocks will have 
better hospital outcomes. 
2. I also hypothesize that patients’ who received PAI will have lower TKA 
hospitalization cost. 
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CHAPTER 2 
LITERATURE REVIEW 
 
STUDY I: REVIEW OF LITERATURE 
SIGNIFICANCE OF CANCER IN THE UNITED STATES 
Cancer is a major public health problem in the United States (U.S.) and the 
second-leading cause of death among Americans [59]. In 2012, an estimated 1,529,078 
people were diagnosed with cancer in the U.S., and 582,607 people died of the disease 
[60]. In 2013, there were an estimated 14,140,254 people living with cancer of any site 
[61]. In 2016, it was estimated that there 1,685,210 new cases of cancer of any site will 
emerge, with 595,690 estimated deaths [62]. According to cancer statistics, death rates 
for cancer are higher among the middle-aged and elderly populations [61]. The percent of 
cancer of any site deaths is highest among people aged 75-84 (26.9%). Overall cancer 
age-adjusted incidence rates are higher among men than women (504.5 vs. 409.9 per 
100,000) respectively.  Among racial and ethnic groups, there are more new cases among 
African American men (571.8 per 100,000) and white women (422.5 per 100,000) and 
fewer new cases among Asian/Pacific Islanders of both men and women 317.3 and 296.7 
per 100,000) respectively.  
Among men, prostate (105.3 per 100,000), lung and bronchus (71.6 per 100,000), 
colon or rectum (44.8 per 100,000), and urinary bladder (35.4 per 100,000) were the most 
common cancers. Among women, breast (122.2 per 100,000), lung and bronchus (52.1 
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per 100,000), colon and rectum (34.1 per 100,000), and uterine corpus (25.7 per 100,000) 
cancers occurred most frequently [62]. The Agency for Healthcare Research and Quality 
(AHRQ) estimated that for 2012, the direct medical costs for cancer, including all health 
care expenditures, were $87.5 billion, which is about 6.7% of total spending [63]. These 
costs are more likely to increase due to the increased burden of the disease and aging of 
the U.S. population. To meet these challenges, new approaches to healthcare delivery and 
comprehensive population health management, education and awareness are required.  
INFORMATION: A CRITICAL NEED FOR CRITICAL PATIENTS 
Cancer patients usually face multiple active conditions, complex tests, procedures, 
and treatments. These overwhelming conditions increase their need for information 
support about their health status, and make them eager to better understand their 
diagnosis, prognosis, and options for treatment [19, 64, 65]. Kowalski et al. 2014, found 
that breast cancer patients who are younger, those receiving mastectomy, having health 
insurance, not living with a partner or having a foreign native language reported higher 
unmet information needs in hospitals [65]. Beckjord et al. 2008, studied a heterogeneous 
sample of cancer patients and found that cancer survivors who were younger, had 
comorbid health conditions or had worse physical or mental health had more information 
needs [66]. In a population-based study, Nagler and colleagues reported that the rate of 
information-seeking varied by tumor type, where patients with breast or prostate cancer 
had higher information-seeking behavior than did patients with colorectal cancer, and the 
differences were most pronounced in patients with early-stage disease [67]. Many 
patients are increasingly using the Internet to acquire information, especially through 
Web-based materials [68]. Online Cancer information seekers tend to be younger, more 
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educated, and higher-income patients [69, 70]. Although the Internet is the most cited 
source of cancer information, a survey involving patients receiving treatment for lung 
cancer showed that only 16% actually sought information from the Internet [71]. This 
study has also found that the Internet-derived information was perceived to be of a 
similar quality to other non-clinical sources, suggesting that trust in the Internet is not 
always the primary or only factor impacting patients to act on its information. According 
to Shea–Budgell and colleagues, cancer patients believe that their health care provider is 
the most trusted source of cancer information [72]. This finding is also supported by a 
study focused on prostate cancer patients where they reported their doctor or other health 
care providers as the trusted information source [73]. Among breast cancer patients, a 
background survey showed that 86% of participants 'agreed' or 'strongly agreed' that 
having reliable information approved from the hospital would make them feel more able 
to make decisions about their treatment and disease [74]. Therefore, healthcare providers 
have a responsibility to build better communication structure with their patients and meet 
their information needs. Delivering appropriate information in a strong communication 
and trust environment is a crucial enabling factor that supports patient-centered care, 
which is a ‘fundamental paradigm shift’ in healthcare delivery according to the World 
Health Organization  [75]. The concept of patient-centeredness is specifically defined by 
the Institute of Medicine (IOM) as “care that is respectful of and responsive to individual 
patient preferences, needs, and values” [30]. In a patient-centered environment, 
information exchange between providers and patients goes beyond just providing facts 
and figures to tailoring information in response to an understanding of a patient’s 
concerns, beliefs, and expectations. Evidence suggests that a patient-centered approach is 
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strongly associated with satisfaction, better engagement and adherence to treatment, and 
improved health and quality-of-life outcomes [76-78].  
In today's healthcare system, information technology is the foundation of the 
future. Unfortunately, most health care-related information technology investments have 
been concentrated on the administrative and financial side, rather than on clinical care 
(Reid, 2005). As a result, little progress has been made toward meeting the information 
needs of patients and providers. However, current electronic patient portals have brought 
new opportunities for efficient and high-quality patient centered care by providing 
patients’ access to their own clinical information [15].  Since 1996, the Health Insurance 
Portability and Accountability Act (HIPPA) guaranteed patients’ rights to review their 
health records [79]. However, before the digital age, patients’ medical records were 
paper-based, and patients’ demand for their own records had barriers due to cultural and 
practical reasons or due to concerns by health care practitioners [80]. Also, illegible 
handwriting, time delays and photocopying costs were other factors that hindered 
information access [17]. Nowadays, the transition to electronic health records (EHR) has 
become a significant factor in medical practice and healthcare systems. It has enhanced 
the IOM principles of patient safety, timeliness, efficiency, and patient centeredness [30]. 
Many institutions are implementing electronic portals linked with EHR to fulfill patients 
need for information and provide them with prompt access to their updated clinical 
records. This information exchange will eventually transform the delivery of care on all 
levels of the health care delivery system, the patient, the care team, and the overall health 
care organization.  
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PATIENT PORTAL USE AND IMPACT ON MEDICAL PRACTICE 
Recently, patients do recognize the benefits of portals. In a nationwide survey 
conducted in 2011, 70% of patients indicated interest in portal access if that was available 
for them [81]. However, a recent systematic review demonstrated that patients’ interest 
and ability to use patient portals is strongly influenced by personal factors such age, 
ethnicity, education level, health literacy, and health status [20]. A cohort study at Kaiser 
Permanente Georgia found that portal registration was more likely among whites, those 
with Internet access at baseline, and those with more education [82]. A cross sectional 
observational study by Goel and colleagues at an academic primary care practice found 
that White patients were significantly more likely to enroll in patient portals than black, 
Latino, and Asian patients (74% vs. 55%, 64%, 66%, respectively, p<0.05) [83]. A study 
by Weppner and colleagues found that younger age, male sex, higher socioeconomic 
status and greater illness rates were associated with earlier portal registration [84]. Group 
Health Cooperative found that portal adopters were more likely to be with commercial 
insurance and higher than expected clinical need [85]. Among portal registrants at the 
Cleveland Clinic, whites were more likely than blacks to use the account after registering 
for it [55]. Yamin and colleagues compared primary care patients who had activated their 
portal account with those who had not, and found lower utilization among all racial 
minorities [86]. In contrast, Phelps and colleagues observational study found a greater 
portal use among those with more medical problems, particularly those with chronic 
diseases [87]. A retrospective study conducted in New York found greater portal access 
among those with private insurance [88]. The University of Pittsburgh evaluated the 
characteristics of portal users and found higher access among those in poorer health, as 
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indicated by greater numbers of diagnoses and medications [89] . In a large oncology 
cohort, greater healthcare need as expressed by disease burden and case complexity was 
associated with portal use [24]. 
Studies indicate that information features enabled by patient portals are intended 
to make patients more active in managing and monitoring their health. Thus, patients who 
are armed with information about their condition make more informed choices about their 
own health care and have greater satisfaction with treatment choices and quality of life 
[17]. They also have better adherence to safety practices, better compliance and 
partnership with the healthcare team, and possibly participate more in clinical trials and 
further research [29].  Other studies found that engaging patients in their care will 
improve their experience and enable them to take responsibility for their own care after 
discharge [80, 90]. 
Several studies showed that access to electronic records in the outpatient setting 
have increased their ability to self-manage chronic health conditions, medication tracking 
and provided a safe way to renew their prescriptions [21, 91]. It has also increased the 
ability to utilize appointment time more effectively, to prepare patients for appointments 
by accessing results of previous tests and medications, and to interact efficiently with 
clinicians for clarifying unclear information [16]. Despite potential advantages, 
systematic reviews demonstrated that the most frequent obstacles reported on using 
the portals were the complexity faced by those who lack technology experience, 
frustration faced by complicated medical terminology, and anxiety and confusion when 
information is viewed without concurrent clinical interpretation, which cause mutual 
distress for patients and providers [24, 74, 92].  
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However, most published studies about patient portals describe its use in the 
primary care or ambulatory settings, with little experience reported on hospitalized 
patients. In fact, patients need more information and engagement when they are admitted 
to the hospital to reduce their feeling of isolation, uncertainty, and anxiousness [33, 93]. 
A controlled trial by O’Leary and colleagues provided the hospitalized intervention group 
with a mobile portal, and found that the application was able to increase the patients’ 
knowledge of physician names and roles [94]. A qualitative study by Greysen and 
colleagues evaluated the impact of providing tablet computers with an educational 
module on patient safety and patient portal access to a pilot sample of 30 hospitalized 
patients, and found it to be useful for increasing patients’ engagement [95]. Among 
cancer patients, only a few studies have described the pattern of portal use and none was 
found to evaluate associated outcomes. In a cohort of patients with hematologic 
malignancies, 89% expressed interest in accessing electronic health records [90]. In 
another study among breast cancer patients, 98% reported that having access to their 
personal electronic health record would help them manage their care [74]. In a 10-months 
study of 186 ambulatory patients with brain tumor, 60% had accessed a personal health 
record at least one time during the study period, and access was significantly associated 
with the reduction of their disease-related uncertainty [23]. A retrospective study among 
heterogeneous cancer patients seen in a national cancer center, online electronic medical 
record portal use was associated with younger age, white race, and an upper aerodigestive 
malignancy diagnosis [24]. In this latter study, the majority of patient access occurred 
during clinic hours, which suggests that access is more common when patients were in 
the hospital.  
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MAYO CLINIC PATIENT PORTAL 
Mayo Clinic is a tertiary care non-profit medical practice that is recognized for 
high-quality patient care. It is regarded as one of the world's greatest hospitals and ranked 
No. 1 on the 2014–2015 U.S. News & World Report List of "Best Hospitals", 
maintaining a position near the top for more than 20 years (Harder 2015). The Clinic was 
first based in Rochester (Minnesota), and currently has major campuses in Jacksonville 
(Florida), and Phoenix (Arizona), along with the Mayo Clinic Health System, which 
consists of more than 70 hospitals. The institution has a three-part focus: patient care, 
research, and education, which are represented by the shields in the Clinic logo. It also 
has a history of investing in innovation by implementing projects that transform the 
experience and delivery of healthcare through conducting continuous assessments and 
improvements in the medical practice. 
Innovative applications, particularly electronic patient portals were implemented 
in Mayo Clinic to contribute to the patient-centeredness approach, aligning with the 
primary statement of the organization that "the needs of the patient come first". MCF 
contracted with Cerner solutions to implement the patient portal and integrated it with the 
system-wide electronic medical record in 2010. When patients schedule an appointment 
at MCF, they are invited to register for a portal account and are provided with 
information on why and how to register. With each appointment reminder, patients 
receive a re-invitation message to the portal. Portal invitations are also offered in all 
outpatient waiting areas and displayed on electronic screens around the clinic. Once 
registered, patients are able to access his or her account via a password-protected 
encrypted Mayo Clinic website or mobile application on Android, Apple, or Amazon 
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devices. The portal includes informational functions, such as viewing lab results, current 
medications, allergies, and diagnostic reports from clinic visits and hospitalizations, and 
administrative functions, such as paying bills, processing prescription refills, and 
coordinating appointments. A Continuity of Care Document (CCD), a complete summary 
of patient current health status and history, is also available to view, download, or 
forward to physicians at other hospitals. Although the portal is designed for outpatients, 
some functions are applicable to inpatient health information needs during the hospital 
stay. Hospitalized patients have considerable time when they are not occupied with 
diagnostic testing or other activities, which can be better utilized. For example, the portal 
gives inpatients real-time access to lab results, admission notes, consultation reports, and 
surgical notes, to view on their own time and between bedside rounds. This functionality 
potentially facilitates patient communication and interaction with the healthcare team 
during their stay, and empowers the patient to be more attentive toward errors in 
documentation. In addition, the medication function provides patients with information 
on the type and purpose of their medications, including in-hospital medication intake, 
which could enable patients to ask questions, review for accuracy, or report medication 
discrepancies. Before home discharge, a discharge summary and discharge instructions is 
uploaded to the portal, giving patients time to review closely and ensure their 
understanding of home self-management instructions. While the development of portal 
functionality for inpatients is in early stages, the offered content may still help patients 
become more activated and improve post-discharge care. 
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STUDY II: REVIEW OF LITERATURE 
BURDEN OF JOINT DISEASES AND THE NEED FOR TOTAL KNEE 
ARTHROPLASTY 
Arthritis is the most common cause of chronic knee pain and disability. Although 
there are many types of arthritis, most knee pain is caused by just three types: 
osteoarthritis, rheumatoid arthritis, and post-traumatic arthritis [96]. Total knee 
arthroplasty (TKA), also called total knee replacement, is a common orthopedic operation 
and an effective treatment for reducing severe arthritis pain and restoring the mobility of 
patients [96]. Murphy et al. estimated that nearly half of all adults in the United States are 
at risk of developing symptomatic knee osteoarthritis by 85 years of age [97], and 
Weinstein et al. estimated that over half of the U.S. adults diagnosed with knee 
osteoarthritis will undergo a TKA in some point in their lives [98]. The latter study also 
estimated that the lifetime risk of primary total knee replacement from the age of 25 years 
was 9.5% for women and 7.0% for men, increasing with age [98]. However, recent trends 
are indicating an increase in prevalence over time and a shift to younger ages less than 65 
years [52, 99].  Further studies found higher TKA procedure rates in women than in men, 
in whites than in blacks, in those with higher incomes than in those who received 
Medicaid supplementation, and in those living in the West North Central and Mountain 
regions than other areas [100]. The rapid increase in TKA surgeries each year can be 
attributed to the growth in life expectancy, aging population, surgical technical 
advancements, and the increasing prevalence of population risk factors causing joint 
problems [29, 52].  
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PAIN MANAGEMENT AFTER TKA 
Total knee arthroplasty have proven to be the most successful surgical 
intervention aimed at improving mobility and quality of life among patients with arthritis 
[101-103].  Yet, postoperative pain is one of the main concerns of patients undergoing 
this procedure, and achieving satisfactory postsurgical pain control is a critical factor for 
successful recovery [104-106]. Given the importance of the pain experience, the Joint 
Commission and the Agency for Healthcare Quality and Research (AHRQ) introduced 
standards for organizations to improve their care for patients with pain.  
In the last few years, clinicians’ tended to focus more on pain management since 
severe pain has profound implications on patients’ quality of life [107, 108]. 
Advancements in postoperative pain control headed toward multimodal pain management 
approaches instead of using opioids alone [109]. Of these approaches, femoral nerve 
block (FNB) which is a well-established analgesic to reduce pain post-TKA and seen as 
the gold standard [110, 111]. However, many authors reported a number of disadvantages 
including quadriceps weakness that delays recovery, increases risks of neurological 
symptoms, falls, opioids consumption, and complications [43, 112, 113]. For this reason, 
some clinicians combine sciatic nerve block (SNB) to a FNB, instead of using FNB 
alone, in order to improve outcomes early after surgery [114-118]. Yet, the advantages of 
SNB when combined with FNB continue to be debated in the literature [119, 120].  
Compared with peripheral nerve block, periarticular anesthetic injections (PAI), a 
concentrated multi drug injection, have been identified as a preferred alternative approach 
for pain management after TKA [121]. Earlier clinical studies have been conducted to 
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validate the efficacy and safety of different combinations of the PAI drug mixture, and 
reported it to be easier to administer and have better patient outcomes [122-124].   
Kirkness et al retrospectively compared patient outcomes who recieved PAI with 
liposome bupivacaine versus those who received FNB, and found that more patients’ in 
the PAI group walked on the day of surgery (22% versus 3%, p< 0.05), more likely to be 
discharged within two days (50% versus 19%, p<0.001), and had shorter length of stay 
(3.1 days versus 3.6 days, p<0.03)  compared to the FNB group [125, 126]. Tfadhhol and 
colleagues randomized clinical trial presented data suggesting that PAI with ropivacaine, 
ketorolac, and epinephrine results in faster postoperative ambulation, as indicated by 
being better able to walk more than 3 meters on the first postoperative day (POD) (74% 
versus 19%. p<0.001) compared to FNB [127]. Affas and colleagues measured pain 
during the first 24 hours after TKA, on a numeric rating scale (0–10), and found that pain 
intensity at rest was marginally lower with infiltration (mean score: 1.6 versus 2.2) than 
with FNB [128]. 
Still, other published studies found controversial conclusions.  Wang et al meta-
analysis found that single-injection FNB have better pain relief in the early postoperative 
period compared with single and continuous periarticular multimodal drug injections, 
with no significant difference seen in post-operative complications between the two 
groups [129]. DeWeese et al conducted a retrospective comparison and found that other 
injection mixtures such as those with containing fentanyl and bupivacaine resulted in 
better pain relief than did continuous injection of the knee with bupivacaine [40]. 
Spanghel et al clinical trial used PAI mixture of ropivacaine, epinephrine, ketorolac, and 
morphine and found patients who received it had shorter length of stay compared to those 
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who received FNB (2.44 days versus 2.84 days; p=0.02), while no differences in mean 
pain scores taken in three times points post-surgery were observed between the groups 
[50].  
Recent studies in the literature presented comparisons of direct hospital cost 
associated with the two pain management approaches. In a single-site retrospective 
cohort study of 268 patients, the mean adjusted total hospitalization cost per patient was 
significantly lower among patients who received PAI with liposomal bupivacaine 
compared to FNB ($8,758 versus $9,213, p=0.033) [126]. Similar conclusions were 
found in a pre-post study among 125 TKA cases performed using either PAI with  
liposomal bupivacaine or FNB, and found that the average hospitalization cost was 
significantly lower with PAI compared to FNB ($26,472 versus $28,546; p< 0.001) 
[130].  
National calculations of aggregate annual costs for TKA hospital stay indicated 
that it was the second most costly procedure at $11.3 billion after spinal fusion at $12.8 
billion [131]. Therefore, it is suggested that effective pain management will influence 
patients to regain mobility, facilitate recovery, decrease length of hospital stay and 
consequently lower cost.  However, consistent evidence on PAI as better alternative to 
other pain management approaches is limited and research is needed to support its 
efficacy [132-136].  Interestingly, healthcare payers and policymakers are currently 
targeting total joint arthroplasty as an area for quality improvement and healthcare cost-
savings initiatives [137, 138]. In addition, because many surgical procedures have 
migrated to the outpatient setting, stakeholders may be interested in pain control 
approaches that enable easier and safer TKA that can be provided at lower cost.  
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TKA IN MAYO CLINIC 
In Mayo Clinic, TKA represents the most common elective hospital admission.  
The Department of Orthopedics has enjoyed a phenomenal reputation for providing this 
procedure successfully, leading to an extraordinary number of patients seeking care.  In 
fact, the first FDA-approved total joint arthroplasty in the U.S. was performed at Mayo 
Clinic 45 years ago (first total hip arthroplasty - March 10, 1969 by Dr. Mark Coventry 
and team at Rochester Methodist Hospital).  Since then, Mayo orthopedic care has 
routinely ranked among the very best in the country.  Today, Mayo destination sites in 
Rochester, Arizona, and Florida perform more than 6000 TKA per year, making it one of 
the largest practices in the U.S. As such, this service line justifies the work and attention 
to better delineate objective measurement of quality, cost, and the value of provided care. 
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CHAPTER 3 
METHODOLOGY 
 
STUDY I METHODS  
STUDY DESIGN AND SAMPLE: 
This was a retrospective review of patients satisfying the following criteria: (1) 
adults (≥18 years old), (2) had cancer as a primary or secondary diagnosis at time of 
hospitalization identified through the International Classification of Disease (ICD-9) 
codes, and (3) admitted to MCF between August 1, 2012 and July 31, 2014 (N=4594). 
Per the unified theory of acceptance of use of technology (UTAUT), user acceptance and 
intention to use of information technology is subsequent by usage behavior [139]. Thus, 
we included the first hospitalization where a portal account had been established prior to 
admission to examine consequent inpatient use. If the patient had not established a portal 
account prior to any admission, then the first hospitalization in the study period was 
selected. Patients who had a portal account prior to admission were defined as 
“adopters”, and those without a portal account were “non-adopters”. Among adopters, 
inpatients who logged in their portal during the hospital stay were “active inpatient users” 
and those who never logged in were referred to as “inactive inpatient users”. The study 
cohorts and sample size are presented in Figure 3.1.   
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Figure 3.1 Study I Cohorts and Sample Size 
  
Patient Portal in MCF
(Aug 2012-July 2014)
Adopters (N=2352)
Inactive Inpatient Users 
(N=1720)
Active Inpatient Users 
(N=632)
Non-Adpoters 
(N=2242)
  
28 
 
CONCEPTUAL MODEL: 
A study theoretical model was developed based on Andersen’s model of 
Healthcare Utilization (Figure 3.2). Andersen’s model was initially developed to 
understand health services use and later revised to include consumer satisfaction and 
dimensions of health status [140, 141]. Shortly after the model was developed, health 
services use was portrayed as a health behavior influenced by multiple factors [142]. 
According to the World Health Organization (WHO), health behavior was defined as 
“any activity undertaken by an individual, regardless of actual or perceived health status, 
for the purpose of promoting, protecting or maintaining health, whether or not such 
behavior is objectively effective towards that end” [143]. Because the portal is a tool to 
maintain and promote health, we considered portal adoption and inpatient use as health 
behaviors that could be studied using Andersen’s model. We assumed that all study 
participants had a common environmental context, as all patients in MCF received their 
care in the same structure. Patient characteristics were classified into predisposing, 
enabling, and need factors as described in the model below. 
 
STUDY MEASURES: 
A. Predisposing Factors: 
This included demographic variables such as gender (male as the reference 
group), age (categorized as: 18-44, 45-54, 55-64, 65-74 “reference”, 75-84, and 85 or 
above), and race (categorized as Caucasian “reference”, African American, and Other 
group that includes Asian, Native Hawaiian or other Pacific Islander, American Indian, 
and those with more than one race.  
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Figure 3.2 Study I Theoretical Model  
1 Predisposing factors: age, sex, and race. 
2 Enabling factors: marital status, employment status, health insurance type, and income. 
3 Need factors: geographic area of residence, comorbidities, and frequency of 
hospitalizations.  Additional need factors related to the admission: MSDRG type and 
APRDRG disease severity weight. 
  
Environment 
 
MCF 
  
 
Adoption  
 
Active 
Inpatient Use 
 
(1) Patient Safety: 
Had an adverse event 
 
(2) Post-discharge care 
Utilization: 
- Emergency visit within 14 days 
- Unplanned readmission within 
30 days 
 
(3) Patient Satisfaction: 
- Self-health management 
knowledge 
- Overall hospital experience 
 
Predisposing1 
 
Enabling2 
 
Need3 
Patient Factors Portal Behavior Outcomes 
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B. Enabling Factors: 
This included social and financial factors, including marital status (broken into 
divorced, married “reference”, single and widowed), employment status (broken into 
disabled, employed “reference”, not-employed, retired, and unknown, where patients did 
not report their employment in their registration forms). Initial analysis showed a large 
segment of the study sample with unknown employment, and that is why it was included 
and analyzed as a category. Geographical area of residence was broken into international, 
national, regional (North East Florida and South Georgia), and local (Jacksonville area), 
where “local” was used as the referent level.  
Financial factors included health insurance type (broken into governmental (i.e., 
Medicare & Medicaid) “reference”, and non-governmental insurance (i.e., commercial 
insurance and self-payers). Self-payers were less than 3% of the sample, thus was 
included as a separate category. We reported whether patients had a median household 
income less than Florida’s state median income ($48,277) based on their residential ZIP 
code, a surrogate for socio-economic status. The median household income was extracted 
from the most recently available (2006-2010) American Community Survey (ACS), 
matched to our sample at the ZIP code level [144]. We were unable to match 1% of the 
sample with ACS, either due to being an international patient or no data was available in 
ACS for the patient ZIP code, thus, patients were assigned the average median income for 
the study sample. 
C. Need Factors: 
This category included the frequency of hospitalizations in the study period as a 
continuous variable and number of comorbidities categorized in three groups: no 
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comorbidities “reference”, one to two, and three or more. Comorbidities were counted by 
the presence of any Deyo-Charlson diseases “yes/no” 12 months prior to the encounter. 
Deyo-Charlson is a validated measure to categorize comorbidities of patients based on 
the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-
CM) diagnosis codes found in administrative data [145]. The original Index was 
developed with 19 categories, but has been modified to 17 categories, which are 
myocardial infarction, congestive heart failure, peripheral vascular disease, dementia, 
ulcer, cerebrovascular disease, chronic pulmonary disease, mild liver disease, metastatic 
solid tumor, tumor without metastasis, diabetes, diabetes with organ damage, hemiplegia, 
moderate or severe renal disease, moderate or severe liver disease, aids, and 
rheumatologic disease. We excluded the count of metastatic solid tumor and tumor 
without metastasis categories as all patients included in the study do have tumor, and our 
interest was to count other existing diseases.  
Additional need determinants related to the hospital admission were documented 
including admission service (medical “reference” versus surgical) based on the Medicare 
Severity-Diagnosis Related Group (MSDRG) codes. We also documented disease 
severity weight as measured by “All Patient Refined Diagnostic Related Groups” 
(APRDRG) classification system, which classifies patients according to their reason of 
admission, severity of illness and risk of mortality [146].  
D. Outcomes: 
1. Emergency visits within 14-days after discharge obtained from hospital internal 
records. (categorical: yes/no) 
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2. All cause unplanned readmission within 30-days after discharge obtained from 
hospital internal records. (categorical: yes/no) 
3. Patient Satisfaction, obtained from the Hospital Consumer Assessment of Healthcare 
Providers and Systems (HCAHPS) survey[147]. HCAHPS is a national standard 
validated survey to measure patients' perspectives on hospital care developed by the 
Centers for Medicare & Medicaid Services (CMS) and the Agency for Healthcare 
Research and Quality (AHRQ)[148]. HCAHPS in Mayo Clinic was distributed by 
mail to a random sample of patients between 48 hours and 6 weeks after discharge. 
The survey is 32 questions in length. However, initial analysis showed low received 
responses and therefore we could not include all survey questions, and selected the 
relevant items with highest response. We also could not calculate the response rate as 
MCF contracted with an external company “Cerner” for data collection, and the 
agreement included only returned surveys, which was hence a study limitation.  
We measured patient self-health management knowledge with two questions: 
1.  HCAHPS 24: When I left the hospital, I had a good understanding of the things I was 
responsible for in managing my health, 
2. HCAHPS 25: When I left the hospital, I clearly understood the purpose for taking 
each of my medication, 
and measured overall hospital satisfaction with one question: 
3. HCAHPS 21: Using any number from 0 to 10, where 0 is the worst hospital possible 
and 10 is the best hospital possible, what number would you use to rate this hospital 
during your stay. 
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 Responses were transformed and averaged, resulting in a 0 to 100 linear-scaled 
score as follows: ("Strongly Disagree" = 0; "Disagree" = 33.3; "Agree" = 66.7; and 
"Strongly Agree" = 100) for HCAHPS questions 24 and 25, and (Overall Rating "0" = 0; 
Overall Rating "1" = 10; Overall Rating "2" = 20; …; Overall Rating "10" = 100) for 
HCAHPS question 21. 
DATA ACQUISITION: 
Data was extracted from the EHR and the Decision Support System (DSS). These 
two databases were matched to obtain information on patient characteristics and 
outcomes for the selected hospitalization. HCAHPS patient experience data were 
obtained from the quality management department. 
DATA ANALYSIS: 
We described the characteristics of oncology patients according to their portal 
adoption and inpatient activity behaviors and examined differences between groups using 
Pearson χ2 and Wilcoxon nonparametric tests. Univariate and multivariable logistic 
regression models were used to test the association between patient characteristics, and 
adoption behaviors separately adjusting for patient characteristics. Multivariate logistic 
and linear regression models were used to examine the association between outcomes and 
portal behaviors. Statistical analyses were performed using SAS Version 9.4 (SAS 
Institute Inc., Cary, NC, USA), and significance was defined as P<0.05. Detailed analysis 
plan is shown in Table 2. 
BUDGET:  
 None 
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ETHICAL CONSIDERATIONS: 
The study proposal was approved by the Institutional Review Board (IRB) in 
Mayo Clinic (# 14-006039). All extracted data were stored on a password-protected 
server known only to the researcher.  
CONFLICT OF INTEREST:   
 None 
 
STUDY II: METHODS 
STUDY DESIGN AND SAMPLE: 
This was a retrospective chart review of patients who were at least 18 years of age 
and received a primary unilateral total knee arthroplasty at Mayo Clinic Florida. 
International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) 
and International Classification of Diseases, 10th Revision, Clinical Modification (ICD-
10-CM) procedure codes for total knee arthroplasty were used to extract eligible patients, 
as the practice transitioned to use the later coding system in December 2014. A total of 
1158 TKA patients were screened to obtain 990 eligible patients for the study. Figure 3.3 
illustrates the process of screening patients for eligibility. We compared patients cohorts 
who received FNB combined with single-shot SNB for pain control after TKA between 
March 1, 2013 and August 31 2014 versus patients who received PAI between October 1, 
2014 and March 31, 2016.  
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Table 3.1 Detailed analysis plan for Study I 
Objectives Comparison groups Variables Type of analysis 
 
 
Question #1 
 
Patient Characteristics 
 
Adopters vs. non-adopters 
 
 
 
 
Predisposing, enabling, and 
need factors 
 
1. Descriptive analyses including 
frequencies, means and standard 
deviations, and percentages as 
appropriate.  
 
2. Examine differences between 
groups using Pearson χ2 and 
Wilcoxon nonparametric test. 
 
Among adopters: 
Active vs. inactive inpatient 
users 
 
 
 
Question #2  
 
Predictors for adoption 
 
 
Dependent: 
Portal Adopter: Yes/no 
 
 
 
Adjusting for patient 
predisposing, enabling, 
and need factors  
 
 
 
Logistic regression model for each 
dependent variable 
 
 
Question #2 
 
Predictors for active 
inpatient use 
 
 
Dependent: 
Active inpatient user: Yes/no 
 
Question #3 
 
Association of inpatient 
portal behaviors and 
outcomes 
Dependent: (5 separate models) 
1. Adverse event (yes/no) 
2. Emergency visit (yes/no) 
3. Readmission  (yes/no) 
4. Self-management knowledge 
score 
5. Overall satisfaction score 
 
Portal behavior:  
nonadopter (reference),  
active inpatient user, 
 inactive inpatient user 
 
adjusting for age and disease 
severity (APRDRG weight) 
 
Logistic regression for adverse 
events, emergency visits, and 
readmissions. Linear regression for 
self-health management knowledge 
and overall hospital experience 
scores. 
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Figure 3.3 Study II Flow diagram of patients’ exclusions and eligibility 
*Exclusion criteria in the 90-day follow up period are not mutually exclusive. 
Cases met inclusion criteria 
(n=990)  
 
Excluded (n=168) 
1. Bilateral and Revision surgeries, (n=11) 
2. Patients with prior TKA or partial knee replacements, (n=104) 
3. Had TKA procedure during the change period (Sep 2014), (n=24) 
4. Had overnight TKA; LOS<24hors, (n=2) 
5. American Society of Anesthesiologists score > III, (n=6) 
6. Patients who did not receive FNB or PAI, (n=21) 
 
Analyzed (n=278) Analyzed (n=263) 
Index Hospitalization 
90-day Cost Analysis 
Received PAI 
(n=479) 
 
Received FNB combined with SNB 
(n=511) 
Excluded (n=248) 
1. Had major elective surgery 
readmission, (n=27) 
2. Patients not living locally, (n=235) 
3. Outlier cost > $20,000, (n=6) 
 
 
 
Excluded (n=201) 
1. Had major elective 
surgery readmission, 
(n=24) 
2. Patients not living 
locally, (n=190) 
3. Outlier cost > $20,000, 
(n=5) 
 
90-day Follow-up* 
Total Knee Replacement cases assessed for eligibility 
(n=1158) 
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DESCRIPTION OF THE PAIN MANAGEMENT APPROACHES 
Identical surgical procedure, implants, and same surgery team with similar patient 
distribution for each surgeon, performed TKA in the two periods, minimizing the chance 
for variability and provider factors. For patients who received FNB combined with 
single-shot SNB, the same anesthesiologist performed the anesthesia for all cases, using a 
pre-procedure sedation with 0.5 mg midazolam and fentanyl. After that, patients had an 
indwelling continuous femoral catheter supplemented with a single-shot SNB in cases 
that did not have significant valgus deformity or radiculopathy.  Ultrasound imaging aids 
the anesthesiologist in placing the needle in exactly the right location, under surgical 
aseptic conditions. For patients who received PAI, the anesthetic mixture was 
administered based on weight, as previously used by Spanghel and colleagues in Mayo 
Clinic Arizona and presented in Table 3.2 [50]. PAI was administered by the same 
surgeon, minimizing the potential for confounding effects on injection technique. The 
injection was administered by 18 gauge needle as multiple boluses into the periarticular 
tissue surrounding the knee joint prior to site closure, with no additional infusion or 
injections after site closure. 30cc was placed in the posterior capsule and the rest was 
throughout the anterior knee periarticular tissues and subcutaneous tissues. Detailed 
description of the procedure is explained elsewhere [50]. The efficacy and safety of 
several different combinations of the mixture have been established in earlier studies 
[123, 124, 149].The postoperative pain control was the same for both groups and 
included the use of analgesia such as morphine, acetaminophen, celecoxib, tramadol, and 
narcotics, administered via oral or intravenous means as necessary. 
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Table 3.2 Periarticular injection concentrations: 
Weight (kg) 50-74.9 77-99.9 100-125 
Ropivacaine 200 mg 300 mg 400 mg 
Epinephrine 100 mg 200 mg 300 mg 
Ketorolac 30 mg 30 mg 30 mg 
Morphine sulphate 5 mg 5 mg 5 mg 
Normal saline added to bring volume to 120 mL. 
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CONCEPTUAL MODEL: 
The conceptual model was developed based on Donabedian model of structure, 
process and outcomes (Figure 3.4).   
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 Study II Theoretical Model  
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Our assessed outcomes are also aligned with IOM aims of healthcare quality [30]. 
Please refer to Figure 3.5 that demonstrates how our outcomes are related to those aims, 
putting the issue of patient safety and quality on the radar screen of clinicians and 
policymakers.  
 
 
 
Figure 3.5 Study II outcomes and IOM aims of healthcare quality  
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STUDY MEASURES: 
 A. Patients’ Characteristics: 
Age was reported continuously and broken-down to categories of (<54), (55-64), 
(65-74), and (75 and above) to give a detailed description of the sample, where (55-64) 
group was used as the referent level as it was the majority of our sample.  Body Mass 
Index (BMI) was categorized into normal (18.5-24.9), overweight (25.0-29.9), and obese 
(30.0 and above), based on the BMI classification by CDC. Sex was broken into male and 
female, where the male group was used as the referent level. Race was broken into 
Caucasian “reference”, African American, and Other group that included Asian, Native 
Hawaiian or other Pacific Islander, American Indian, and those with more than one race. 
Marital status variable was broken into either married “reference” or divorced, single or 
widowed. Employment status was broken into employed “reference”, retired, or not-
employed and disabled. Health insurance type was categorized in governmental 
“reference” and non-governmental insurance groups. Tobacco smoking status was 
categorized in ever smoker (i.e., current of former smoker) versus never smokers, where 
the later was the referent group.  
Physical status was measured using the American Society of Anesthesiologists 
(ASA) classification system, a validated measure for preoperative measurement to 
identify patients with an increased risk of death or surgical complications, and rank them 
in groups based on disease severity [102]. The classification adopts a five-category 
classification system ranging from I to IV, but the study will only use; class I: normal 
healthy patient, class II: patient with mild systemic disease (with no functional 
limitation), and class III: patient with severe systemic disease (with some functional 
limitation). Comorbid conditions present during the 12 months prior the index 
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hospitalization was collected based on diseases included in the Deyo-Charlson index, a 
validated measure of comorbidity [145], and categorized in three groups: no 
comorbidities “reference”, one to two, and three or more. We counted additional diseases 
that are not included in Charlson index, and known to be of the most common 
comorbidities associated with patient outcomes in orthopedic care. These include 
congestive heart failure, cerebrovascular disease, peripheral vascular disease, 
chronic pulmonary disease, and anxiety or depression [51, 57, 102, 150]. The top 
comorbidities among patients were reported separately in the descriptive analysis.  
 B. Outcomes: 
All study outcomes were measured postoperatively.  
1. Analgesic effect (continuous): measured by pain scores using a numerical rating scale 
ranging from 0 (No pain) to 10 (Worst possible pain) and reported for the 0-24 hours 
and 24-48 hours interval after surgery. 
2. Functional recovery (continuous): measured by time from end of surgery to first 
walk, and by distance walked each day as documented in physical therapy (PT) notes. 
We then reported cumulative distance walked in the first three PT sessions, which 
was the minimum sessions received by all patients. 
3. Length of hospital stay (continuous): from end of surgery to discharge. 
4. In-hospital falls (categorical variable: yes/no). 
5. Discharge disposition (categorical): whether a patient was discharged to home/ home 
care, or to other facility including skilled nursing facility (SNF), hospice, or 
rehabilitation center. 
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6. Patients’ satisfaction (continuous): measured by the validated Hospital Consumer 
Assessment of Healthcare Providers and Systems (HCAHPS) survey, distributed to a 
random sample of discharged patients ranging between two days and six weeks after 
discharge [147, 148]. Two questions were selected to assess satisfaction with pain: (1) 
“How often was your pain well controlled?”, and (2) “How often did the hospital staff 
do everything they could to help you with your pain?”. One question assessed the 
overall satisfaction with hospital experience: “Using any number from 0 to 10, where 
0 is the worst hospital possible and 10 is the best hospital possible, what number 
would you use to rate this hospital during your stay”.  
7. Cost (continuous), using standardized, inflation adjusted costs for services and 
procedures billed during the index hospitalization and 90-day follow up period.  
8. Emergency visits within 14 days after discharge (categorical: yes/no).  
9. Unplanned readmission for any cause, 30 days after discharge (categorical: yes/no). 
10. Surgery revision within 90 days after discharge (categorical: yes/no), which includes 
prosthesis loosening, wear, and/or osteolysis, instability, infection, bone or prosthesis 
fracture. 
DATA ACQUISITION: 
Patients’ cohorts were identified from the Decision Support System (DSS), and 
then subsequent demographic and clinical data were matched with data in the EHR.  In-
hospital falls were obtained from the quality management department. Patient satisfaction 
data were obtained from the office of patient experience. Responses to satisfaction items 
were transformed and averaged (never=0, sometimes= 33.3, usually=66.6, and always= 
100), resulting in a 0 to 100 linear-scaled score.  Cost data were obtained from the 
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institution cost data warehouse [151],  which applied Medicare reimbursement to 
professional services, multiplied service line hospital charges by Medicare cost report 
cost-to-charge ratios, and adjusted for inflation with the gross domestic product implicit 
price deflator to create 2016 standardized costs. Cost was reported separately for the 
index hospitalization and 90-day follow-up period excluding hospitalization, using 
Berenson-Eggers Type of Service (BETOS) and Uniform Billing-04 (UB04) codes to 
classify the line item data. A further grouping of cost categories was carried out to create 
cost components by  type of service: analgesic approach (i.e., nerve block and the 
periarticular supplies and medications); room and board (i.e., observation and intensive 
care unit stay); operating and recovery room occupation; orthopedic procedure; physical 
therapy; pain medications; laboratory and pathology; supplies; and other costs including 
blood transfusion, other medications/intravenous fluids, and miscellaneous. Follow-up 
cost data did not include medications obtained from outpatient pharmacies. Other 
outcomes such as emergency visits, readmissions, and revisions were collected and 
obtained from the EHR. 
DATA ANALYSIS: 
Analyses utilized SAS version 9.4 (SAS Institute, Cary, NC).  Insignificant 
differences were found in the majority of patient characteristics between the groups. As 
providers were the same surgery team during the study period, there was no risk of 
learning affect among providers in the two cohorts. The distribution of cases per provider 
was tested to ensure consistency, and both surgeons had the same volume of cases. 
Secular trend of specific outcomes (pain scores at 24 and 48 hours, time to first 
ambulation, distance walked in the first 3 PT sessions, postoperative LOS) were tested 
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per cohort using interrupted time analysis, and the consistency of outcomes was ensured 
to be the same within each cohort (P>0.05). Thus, our analysis was focused on comparing 
between the outcomes of patients who had FNB with SNB (group 1) versus PAI (group 
2). Our sample had a non-normal distribution; thus, we performed univariate chi-squared 
test for categorical variables, an independent Wilcoxon signed-rank test for mean 
comparison among continuous variables, with Fisher's exact test for cell counts <40. Cost 
variables were presented as mean and median cost per patient including SDs and 
interquartile ranges. We used repeated generalized linear regression models to determine 
if receiving PAI was a predictor for (1) pain scores at 24 hours, (2) pain scores at 48 
hours, (3) distance walked, (4) postoperative LOS, and (5) total cost of index 
hospitalization. Independent variables in the regression analysis included age, sex, race, 
marital status, BMI, ASA class, and comorbidities. In modelling the index 
hospitalization total cost, we used log-transformed costs. For the 90-day follow up 
period, we excluded selected patient groups (i.e., patients with costs exceeding $20,000 
that was not related to TKA, non-local patients as they were less likely to follow up in the 
Mayo Clinic, and patients who were electively readmitted for major surgeries).  
BUDGET:  None 
ETHICAL CONSIDERATIONS: 
This study was approved by the Mayo Clinic Institutional Review Board. All 
extracted data were accessed using techniques that are in compliance with the Health 
Insurance Portability and Accountability Act of 1996 (HIPAA), and stored on a 
password-protected server known only to the researcher.  
CONFLICT OF INTEREST:  None  
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Table 3.3 Detailed analysis plan for Study II 
Objectives Comparison groups Variables Type of analysis 
 
 
Question #0 
 
Patient 
Characteristics 
 
 
 
 
FNB/SNB vs. PAI 
 
 
 
 
 
 
 
 
Patient demographic and clinical 
characteristics 
1. Descriptive analyses including 
frequencies, means and standard 
deviations, and percentages as 
appropriate.  
 
2. Examine differences between 
groups using Pearson χ2 and 
Wilcoxon nonparametric test. 
 
 
Question #1  
 
Differences 
between groups in 
hospital outcomes 
 
 
 
FNB/SNB vs. PAI 
 
(1) pain scores at 24hr and at 48hr, 
(2) time to first ambulation,  
(3) distance walked in first 3 PT sessions, 
(4) in-hospital falls,  
(5) length of hospital stay,  
(6) discharge disposition, and 
(7) total hospitalization cost 
 
1. Examine differences between 
groups using Pearson χ2 and 
Wilcoxon nonparametric test. 
 
2. Graphic comparison for cost per 
service using bar graph. 
 
Question #2  
 
Differences 
between groups in 
postdischarge 
outcomes 
 
 
 
 
FNB/SNB vs. PAI 
 
 
(1) patient satisfaction,  
(2) emergency department visits /14days, 
(3) unplanned readmissions/ 30days,  
(4) revisions/ 90 days, and  
(5) total cost of follow-up during the 90 
day period 
 
 
Examine differences between groups 
using Pearson χ2 and Wilcoxon 
nonparametric test. 
 
 
Secondary 
analysis 
 
Dependent variables (analyzed 
separately): pain scores at 24 hours, 
at 48 hours, time to first ambulation, 
distance walked, post-operative LOS, 
and total cost of the hospitalization 
 
 
Independent variable:  
PAI (yes/no*) 
 
*no (i.e., FNB/SNB) 
 
 
Several linear regression models, 
adjusting for age, gender, race, 
marital status, BMI, ASA and 
comorbidities. 
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CHAPTER 4 
Manuscript I Patient Portal Adoption and Use by Hospitalized Cancer 
Patients: A Retrospective Study of its Impact on Adverse Events, 
Utilization, and Patient Satisfaction 
ABSTRACT 
Background: Portal use has been studied among outpatients, but its utility and impact on 
inpatients is unclear. This study describes portal adoption and use among hospitalized 
cancer patients and investigates associations with selected safety, utilization, and 
satisfaction measures. 
Methods: A retrospective review of 4,594 adult hospitalized cancer patients was 
conducted between 2012 and 2014 at Mayo Clinic in Jacksonville, Florida, comparing 
portal adopters, who registered for a portal account prior to hospitalization, with 
nonadopters. Adopters were classified by their portal activity during hospitalization as 
active or inactive inpatient users. Univariate and several logistic and linear regression 
models were used for analysis. 
Results: Of total patients, 2,352 (51.2%) were portal adopters, and of them, 632 (26.8%) 
were active inpatient users. Portal adoption was associated with patients who were young, 
female, married, with higher income, and had more frequent hospitalizations (P<.05). 
Active inpatient use was associated with patients who were young, married, nonlocals, 
with higher disease severity, and were hospitalized for medical treatment (P<.05).  
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In univariate analyses, self-management knowledge scores were higher among adopters 
vs nonadopters (84.3 and 80.0, respectively; P=.01) and among active vs inactive 
inpatient users (87.0 and 83.3, respectively; P=.04).  In regression models adjusted for 
age and disease severity, the association between portal behaviors and majority of 
measures were not significant (P>.05). 
Conclusions: Over half of our cancer inpatients adopted a portal prior to hospitalization, 
with increased adoption associated with predisposing and enabling determinants (eg: age, 
sex, marital status, income), and increased inpatient use associated with need (eg: 
nonlocal residence and disease severity). Additional research and greater effort to expand 
the portal functionality is needed to impact inpatient outcomes.  
Keywords: adverse events; cancer; hospitalization; portal; satisfaction; utilization. 
 
INTRODUCTION 
Two decades ago, the National Academy of Medicine (formerly the Institute of 
Medicine recommended implementation of electronic health records to improve quality 
of care in the United States [30]. Since then, health information technologies have been 
rapidly adopted, with a focus on providers rather than patients. In 1996, the Health 
Insurance Portability and Accountability Act legally allowed patients to access their own 
clinical records. However, record retrieval fees, illegible handwriting, and time delays 
hindered accessibility [17]. An additional challenge is the fragmented health system with 
many independently owned and operated health care service locations [19, 152, 153].  An 
integrated information system that aggregates and offers updated health information to 
patients through a single access point was needed. In 2009, the Health Information 
Technology for Economic and Clinical Health Act incentivized clinicians to provide 
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patients with electronic access to clinical records through meaningful use rules, 
administered by the Centers for Medicare & Medicaid Services [34]. This incentive 
program remains the principal driver of patient portal development by funding nearly $30 
billion in provider incentives to encourage appropriate use [24, 154]. Investigations 
where information access was offered via patient portals in the outpatient settings showed 
encouraging positive effects in patient satisfaction and self-management behaviors [14, 
15, 18, 19, 21, 27, 80, 85, 155-157]. However, providing patients access to information is 
important not only in home and outpatient settings, but also when patients are 
hospitalized [93]. 
When patients are able to see their own health information during the hospital 
stay, they become more informed, empowered to ask questions, and gain ownership of 
their health care [158, 159]. Despite daily bedside rounds, important patient informational 
needs may not be met due to the cost of reviewing tailored information with each patient 
individually [160]. Thus, the portal technology may provide opportunity for inpatients to 
meet informational needs, facilitate awareness, and improve understanding of their care 
during hospitalization and after discharge [17, 161]. Meeting informational needs could 
reduce uncertainties surrounding the care process, reduce information asymmetry 
between patients and providers, promote shared decision-making, and increase patient 
self-management and adherence to care [33, 162]. 
Unfortunately, assessments of patient portal use among hospitalized cancer 
patients are limited [23-25, 64, 74, 90]. For many patients, the hospital is a challenging 
and intimidating setting, compounded by unmet information needs and limited patient 
engagement [162, 163]. The rapid dynamic and pace of clinical care, changing medical 
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teams, reliance on verbal communication, and absence of an established relationship with 
the care providers further challenge patients’ effective participation in their own care 
[164, 165]. Additional affective and emotional challenges are faced by inpatients with 
cancer due to the nature of their disease, frequently uncertain outcomes of treatments, and 
the need to understand their multiple active conditions to make treatment decisions [65, 
66]. In a study of breast cancer patients, those who desired an active role in treatment 
decision making also desired detailed information of their diagnosis, treatment 
procedures, and alternatives [166]. Similar information needs were vital to gynecologic 
and colorectal cancer patients who felt that information about the likelihood of cure, 
spread of disease, and treatment options were priorities for decision making [167]. 
Providing clinical information through patient portals may have the potential to transform 
the patient-physician relationship and help patients to become active in their disease 
management [91]. Recent documentation on hospital-based patient portals is encouraging 
[26, 94, 168, 169]. Creber et al published a protocol for developing a personalized 
inpatient portal at an urban academic medical center to improve cardiology inpatients 
engagement [17]. Greysen et al conducted pilot interviews showing patients’ enthusiasm 
for a tablet application that provides health information during their inpatient stay [95]. 
Vawdrey et al assessed the patient-perceived efficacy of tablets to improve cardiothoracic 
surgery patients’ engagement in care, showing a favorable response regarding usability of 
the application [93]. Several other studies assessed the feasibility of web-based 
applications to increase patient engagement in both pediatric and adult care [170-172]. 
Yet, the evaluation of patient portals among cancer inpatients is still limited, a knowledge 
gap addressed by this study. We hypothesized that patient adoption of a portal and active 
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use during a hospital stay may be associated with greater patient safety, postdischarge 
care utilization and satisfaction, similar to outpatient settings. According to Karahanna et 
al, adoption and continued use represent different behaviors [35].  Adoption is the initial 
enrollment and signifies receptivity to the portal, while usage represents active 
engagement, continued use after adoption. Therefore we distinguish between these 2 
behaviors and evaluate them separately. Our specific aims were to 1) identify the key 
patient factors predicting adoption and active inpatient use behaviors, and 2) examine the 
association between portal use behaviors and adverse events, postdischarge utilization 
(emergency visits and readmissions), and selected patient satisfaction measures (self-
health management knowledge and satisfaction with the overall hospital experience). 
MATERIALS AND METHODS 
Study Setting and Description of the Portal  
The site of the study was Mayo Clinic, Jacksonville, Florida (MCF), a large nonprofit, 
specialized tertiary care practice and medical research center with more than 1.3 million 
domestic and international patients seen each year. Physicians are salaried, not linked to 
care volume, thus reducing monetary incentives in patient treatment. MCF contracted 
with Cerner Solutions (Cerner Corp) to implement the patient portal and integrate it with 
the system-wide electronic health record in 2010. When patients schedule an appointment 
at MCF, they are invited to register for a portal account and are provided with 
information on why and how to register. With each appointment reminder, patients 
receive a reminder message to register for the portal. Portal invitations are also offered in 
all outpatient waiting areas and displayed on electronic screens around the clinic.  
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Once registered, patients’ are able to access informational functions, such as 
viewing lab results, current medications, allergies, and diagnostic reports from clinic 
visits and hospitalizations, and administrative functions, such as paying bills, processing 
prescription refills, and coordinating appointments. A Continuity of Care Document, a 
complete summary of patient current health status and history, is also available to view, 
download, or forward to physicians at other hospitals. Additional information on MCF 
patient portal is documented elsewhere [173]. Although the portal is designed for 
outpatients, some functions are applicable to inpatient health information needs during 
the hospital stay. Hospitalized patients potentially have time to access the portal when 
they are not occupied with diagnostic testing or other activities [174]. For example, the 
portal gives inpatients real-time access to laboratory results, admission notes, 
consultation reports, and surgical notes, to view on their own time and between bedside 
rounds. This functionality potentially facilitates patient communication and interaction 
with the health care team during their stay, and empowers the patient to be more attentive 
toward errors in documentation [158]. In addition, the medication function provides 
patients with information on the type and purpose of their medications, including in-
hospital medication intake, which could enable patients to ask questions, review for 
accuracy, or report medication discrepancies [32, 175]. Before home discharge, a 
discharge summary and discharge instructions is uploaded to the portal, giving patients 
time to review closely and ensure their understanding of home self-management 
instructions. While the development of portal functionality for inpatients is in early 
stages, the offered content may still help patients become more activated and improve 
postdischarge care. 
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Study Design and Participants 
 This was a retrospective review of patients satisfying the following criteria: 1) 
adults 18 years of age or older, 2) cancer as a primary or secondary diagnosis at time of 
hospitalization identified through the International Classification of Diseases, Ninth 
Revision (ICD-9) codes, and 3) admitted to MCF between August 1, 2012, and July 31, 
2014 (N=4,594). Per the unified theory of acceptance of use of technology, user 
acceptance and intention to use a technology is followed by actual use [139]. Therefore, 
we included the first hospitalization where a portal account had been established prior to 
admission to examine consequent inpatient use. If the patient had not established a portal 
account prior to any admission, then the first hospitalization in the study period was 
selected. Patients who had a portal account prior to admission were defined as adopters, 
and those without a portal account were nonadopters. Among adopters, inpatients who 
logged in their portal during the hospital stay were active inpatient users and those who 
never logged in were referred to as inactive inpatient users. The study was approved by 
the Mayo Clinic Institutional Review Board. 
Study Model 
 Our study was informed by Andersen’s Model of Healthcare Utilization [140]. 
The model was initially developed in 1968 to understand health services use and later 
revised to include consumer satisfaction and dimensions of health status [142]. Shortly 
after the model was developed, health services use was portrayed as a health behavior 
influenced by multiple factors [141]. According to the World Health Organization, health 
behavior is defined as “any activity undertaken by an individual, regardless of actual or 
perceived health status, for the purpose of promoting, protecting or maintaining health, 
whether or not such behavior is objectively effective towards that end” [143]. Because 
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the portal is a tool to maintain and promote health, we considered portal adoption and use 
as health behaviors that could be studied using Andersen’s model. As shown in Figure 
4.1, we examined the influence of patients’ characteristics in three major components: 
predisposing, enabling, and need factors, on portal adoption and use behaviors. 
   
 
 
 
 
 
 
 
 
 
Figure 4.1 Study Theoretical Model Derived from Andersen’s Model of Healthcare 
Utilization 
1 Predisposing factors: age, sex, and race. 
2 Enabling factors: marital status, employment status, health insurance type, and income. 
3 Need factors: geographic area of residence, comorbidities, and frequency of 
hospitalizations.  Additional need factors related to the admission: MSDRG type and 
APRDRG disease severity weight. APRDRG indicates All Patients Refined Diagnostic 
Related Group; MSDRG, Medicare Severity-Diagnosis Related Group. 
  
Environment 
 
MCF 
  
 
Adoption  
 
Active 
Inpatient Use 
 
(1) Patient Safety: 
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Measures 
Environment and Patient Characteristics 
 In this study, we assumed that all study participants had a common environmental 
context, as all patients in MCF received their care in the same structure. Predisposing 
determinants included age, sex, and race. Enabling determinants included marital status, 
employment status, health insurance type, and median income in the residential ZIP code 
less than Florida’s state median income, a surrogate for socioeconomic status. Need 
factors included geographic area of residence, comorbidities, and frequency of 
hospitalizations in the study period. Additional need determinants related to the hospital 
admission included patient’s disease severity weight as measured by the 3M All Patients 
Refined Diagnosis Related Groups (APDRG) classification system, and whether the 
hospitalization was for medical or surgical treatment, based on the Medicare Severity-
Diagnosis Related Group (MSDRG) codes [146].  
Demographic data were extracted from the patient electronic health records. The 
ZIP code median income was obtained from the 2006-2010 American Community 
Survey and matched to the patient sample at the ZIP code level [144]. A count of 
comorbidities included in Charlson Comorbidity Index during the 12 months prior to 
hospitalization was documented [145].  
Patient Safety, Utilization, and Satisfaction 
 We examined selected patients’ measures to investigate associations with portal 
use. For patient safety, we studied the occurrence or otherwise of provider-reported, in-
hospital, adverse events, such as falls, accidental self-injuries, or other events related to 
the surgery, vascular, equipment or devices, medication, or skin events, obtained from 
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quality management services. For postdischarge utilization, we examined the occurrence 
of emergency department visits within 14 days and unplanned readmissions within 30 
days, both obtained from the hospital records. We measured patient satisfaction by 
obtaining data from the Hospital Consumer Assessment of Healthcare Providers and 
Systems (HCAHPS) survey. The survey is a validated instrument used since 2006 to 
assess patients' perspectives of hospital care, and distributed to a random sample of 
discharged patients between 2 days and 6 weeks after discharge [147]. While the survey 
included many important questions, we selected the relevant items with highest response. 
We measured patient self-health management knowledge with 2 questions: “When I left 
the hospital, I had a good understanding of the things I was responsible for in managing 
my health”, and “When I left the hospital, I clearly understood the purpose for taking 
each of my medications”, and measured overall hospital satisfaction with 1 question: 
“Using any number from 0 to 10, where 0 is the worst hospital possible and 10 is the best 
hospital possible, what number would you use to rate this hospital during your stay” 
[148]. Responses were transformed and averaged, resulting in a 0 to 100 linear-scaled 
score.  
Data Analysis 
 We described the characteristics of cancer patients according to their portal 
adoption and inpatient activity behaviors and examined differences between groups using 
Pearson χ2 and Wilcoxon nonparametric tests. Multivariate regression models were 
conducted to predict factors associated with portal adoption and active inpatient use, as 
well as to examine the association between selected outcomes and portal behaviors. All 
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analyses were conducted in SAS Version 9.4 (SAS Institute Inc, Cary, North Carolina, 
USA), and significance was defined as P<.05. 
RESULTS 
Participants, Adopters, and Active Inpatient Users 
 Of the 4,594 study-eligible hospitalized patients with cancer, 2,352 (51.2%) had a 
portal account prior to admission (ie, adopters), of whom 632 (26.8%) used the portal 
account during their hospital stay (ie, active inpatient users). Patient characteristics at 
admission were reported in Table 4.1. Significant differences in patient characteristics 
were present among portal adoption and inpatient use behaviors (Table 4.2). Adoption 
was influenced by a majority of predisposing and enabling factors, such as age, sex, race, 
marital status, employment status, income, and type of health insurance. While active 
inpatient use was similarly influenced by predisposing and enabling factors, such as age, 
race, and marital status, we found greater influence associated with need, such as having 
greater disease severity, being nonlocal, and admitted for medical rather than surgical 
treatment. 
Bivariate Associations of Portal Behaviors With Adverse Events, Care Utilization, and 
Patient Satisfaction 
Bivariate associations of portal adoption with our selected measures (Table 4.3) 
showed that adopters had more emergency visits and readmissions than nonadopters, 
while reporting higher self-health management knowledge. Similarly, active inpatient 
users had more readmissions than inactive inpatient users, and marginally higher self-
management scores. Logistic and linear regression analyses showed that after adjusting 
for age and disease severity, the association between portal behaviors and majority of our 
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assessed measures were not significant (Table 4.4). Adverse events and overall hospital 
experience did not differ among groups in either univariate or multivariate regression 
analyses (P>.05). 
DISCUSSION  
To date there remains a gap in the literature evaluating the use of inpatient portals 
among cancer patients. This study provides important information to clinicians, 
administrators, and researchers, on the key patient determinants associated with portal 
adoption and use. Prior studies reported significant interest in patient portals among 
oncology populations [64, 74, 176]. Yet, to our knowledge, this is the first study to 
examine portal use in a large inpatient oncology cohort. In this sample, we found that 
portal adoption and use during hospitalization has reached modest levels and somewhat 
higher usage than published reports on inpatient portal use. Over half of our inpatient 
oncology population voluntarily adopted the portal before hospital admission and 27% 
actively used the portal during the stay. Dumitrascu et al found that of 44.2% patients 
who had a portal account at the time of admission, only 20.8% accessed the portal during 
their stay [173]. Davis et al found that of 34.4% registered portal patients, 23.4% used it 
while hospitalized [26]. Robinson et al reported that 16% of surgical inpatients with a 
portal account used it while being in the hospital [177]. 
There were noteworthy differences in patient characteristics between adopters and 
nonadopters in a majority of predisposing and enabling factors. Portal adoption increased 
among patients who were female, married, and with higher income, and decreased among 
patients who were African American, unemployed, and had governmental health 
insurance. Interestingly, the likelihood of portal adoption was similar for patients aged 65 
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to 75 years as the middle-aged adults 45 to 55 years, contradicting popular beliefs that 
older patients were less likely to engage in health technologies [178]. Portal adoption, 
however, considerably decreased among patients aged over 75 years. Similar to our 
findings, portal use among outpatient oncology patients was reported to be greater among 
younger, white patients, and those with upper aerodigestive malignancy diagnosis, 
greater disease severity, and case complexity [24]. Among nononcology populations, a 
similar digital divide was reported by age groups, race/ethnicity, income, and education 
[20, 83, 86, 88, 179, 180]. Our findings showed higher portal adoption among those with 
more frequent hospitalizations, which was the only notable need determinant. Other 
studies have reported higher interest in the portal among those with more medical 
problems, greater severity of illness, or higher than average clinical need [14, 55, 85, 87]. 
Similarly, inpatient portal use increased with younger age and being married, but 
more influenced with need determinants. Active access was associated with residing 
outside the city of Jacksonville (nonlocals); suggesting that commuting patients found 
health information important to view during the stay. Additionally, access was greater 
among those with higher disease severity and those admitted for medical rather than 
surgical treatment. Medical admissions for cancer patients are usually associated with 
investigating the origin and cause of disease, or evaluating chemo or radiation treatments, 
compared to surgical admissions that involve typical procedural routines and surgical 
recovery that may fully occupy the patient’s time in the hospital [181]. Because a cancer 
diagnosis is a stressful life event, patients’ information-seeking behavior was thought to 
become more active, possibly as a coping strategy to overcome uncertainties [23, 74, 
182]. 
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Patient Safety  
Several studies have assumed that information technology systems have the 
potential to improve patient safety by identifying errors in medications and preventing 
adverse drug reactions. Yet, limited evidence exists regarding the effectiveness of a portal 
as a tool in reducing adverse events. One recent study by Kelly et al found that 8% of 
parents with hospitalized children recognized errors in their child's medication list after 
using an inpatient portal application [172]. Further optimistic views about the ability of 
portals to reduce errors were derived from patient participation in care, where patients 
could notify clinicians of their medication allergies, unexpected toxicity symptoms, and 
lapses in care to prevent adverse events [31, 175, 183, 184]. Among surgical inpatients 
who were portal users, postoperative infection was their most frequent ICD-9 code, 
suggesting that experiencing a safety-event may activate patients to follow up their 
personal health information to avoid further complications [177]. In contrast to this 
evidence, our study did not find an association between portal adoption or use and 
adverse events. Likewise, a randomized controlled trial by Weingart et al did not find 
sufficient evidence to support an association between adverse drug events and portal use 
[32]. Earlier research reported that patient history evaluation in cancer care is more 
focused, providing the patient an opportunity to recall medical and medication 
information to prevent errors. [185, 186] In addition, most adverse events at hospitals are 
underreported and the events in our data were limited to those reported by providers. A 
new initiative within the portal that is gaining popularity and has the potential to prevent 
errors is the OpenNotes national movement, which invites patients to read their clinicians' 
notes online and report back errors or safety concerns that, in turn, may avert mistakes 
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from happening [187, 188]. Hence, it opens up a new possibility to engage patients as 
safety partners through their reported documentation errors.  
Utilization 
Studies that examined the effect of portal use on subsequent utilization of health 
services showed mixed results [14, 20, 189]. A study using propensity score matching 
found no difference between portal users and nonusers on clinical service utilization 
[190]. Among members of Kaiser Permanente, a retrospective study in the Northwest 
found that patient access to an online portal was associated with decreased rates of 
primary care office visits and phone calls [191], whereas the opposite was found by Palen 
et al where portal users had higher rates of office visits, phone encounters, after-hour 
clinic visits, emergency department visits, and hospitalizations [192]. The assumption 
was that if patients could view personal health information, they will be more aware, able 
to manage their health, and need less emergency service or hospitalizations. This 
expectation was not validated in our study, suggesting that a portal technology may be a 
complementary technology and does not substitute for health services needs of oncology 
patients. Mayer et al reported 77.2% of cancer patients’ visits to the emergency 
department were due to pain, respiratory problems, and gastrointestinal issues, with 
63.2% of those visits resulting in hospital admission [193]. Barbera et al reported that 
83.8% of cancer patients who died had visited the emergency department during their 
final 6 months of life with issues related to abdominal pain, dyspnea, pneumonia, fatigue, 
and pleural effusion [194]. Shapiro et al found that those who had surgery during their 
index admission were 3 times more likely to be readmitted [195]. Weaver et al examined 
cancer inpatients and found 48% of readmissions were within 1 to 2 days of discharge 
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[196]. Donze et al developed a predictive model and found that discharge from an 
oncology service was a significant predictor of unplanned readmission [197]. Similarly, a 
recent systematic review reported that comorbidities, older age, advanced disease, and 
index hospitalization length of hospital stay were significant predictors for readmission in 
oncology [198]. Thus, emergency department visits and readmissions may be influenced 
more by the nature of illness, treatment-related complications, and other such factors than 
avoidable reasons by portal use.  
Patient Satisfaction 
Our findings suggest limited evidence of the relationship between patient 
satisfaction and portal use. Self-management knowledge scores appear to be considerably 
higher among both adopters and inpatient users in bivariate associations; however, in 
regression analyses, associations with satisfaction were somewhat attenuated and no 
longer statistically significant. Our interpretation of results needs to be cautiously taken 
as they were limited by the random selection of sample surveyed and the selection of 
self-management questions. In addition, we have no assessment of self-health 
management knowledge at baseline. Therefore, the association between portal use and 
self-health management knowledge may have already been existed.  
Prior research has shown inconsistent conclusions regarding associations between 
portal use and patient satisfaction; with wide variability in the offered portal features, the 
outcomes evaluated, and the populations studied [14, 18, 19, 163]. In addition, the 
potential of patient portals for patients with chronic conditions was available, but 
relatively nascent for cancer [199]. Among chronically ill patients, the portal showed 
promise for improving diabetic patients’ satisfaction with care, ability to self-manage, 
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and adhering to treatments [200]. This has been accompanied by evidence of improved 
blood pressure control among people with newly diagnosed hypertension [201]. Patient 
portal access was also superior in general adherence and satisfaction with doctor-patient 
communication among patients with congestive heart failure [80, 202]. Yet, not all 
findings in the literature showed that patients with chronic conditions were amenable to 
improved outcomes with portal use [74, 203-205].  
There are many potential recommendations to improve portal functions for 
inpatients. Hospitals often provide patients and families with standard information on 
disease and treatment options while being hospitalized, but that is not always enough 
[206]. An effective tool for awareness and self-management may include problem-
solving support, regular education provision, treatment options with cost estimations that 
aid patient decision making, and consistent patients training on how to take responsibility 
for their own health [207].  
It should be noted that emotional factors, such as anxiety or low self-efficacy, 
may dramatically influence self-management or symptom-coping behaviors [208, 209]. 
Of interest, some researchers suggest technology-based applications to provide 
recreational social supports to help patients cope with their illness. O’Leary et al reported 
favorable patient perceptions toward games offered in the hospital-based portal [94]. The 
same was reported by Jameson et al, who indicated that electronic gaming can be a 
positive distraction away from pain [210]. Innovative social support approaches offering 
recreational avenues via the portal may attract more users, which in turn, may improve 
self-management, symptom-coping, and quality of life [211]. Thus, greater attention is 
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needed to improve the portal content and functionality for inpatients to improve patient 
outcomes. 
This study has a number of limitations. There is limited generalizability given that 
our oncology cohort was from a single center. Technology limitations restricted our 
analysis; we could not examine frequency of inpatient log-ins, or distinguish if a portal 
activity was carried out by the patient or a delegated family member. Further, it would be 
interesting to understand if there was a dose-response type curve associated with portal 
use but information on the extent of use was not available. Post-discharge utilization 
measures were limited to care utilization at MCF, with no data on utilization elsewhere. 
Conclusions regarding patient safety and satisfaction measures were limited by the range 
of variable values; adverse events were uncommon, and patient satisfaction was almost 
uniformly high among all patients. Finally, low response to the HCAHPS resulted in a 
small sub-sample size to analyze satisfaction, a major limitation, but no other measures 
were readily available. Despite these limitations, the study uncovered determinants of 
adoption and use behaviors among a large sample of hospitalized cancer patients. 
Additionally, it adds new information to the growing body of literature on inpatient 
engagement using acute care portals. Future research directions should investigate the 
extent of inpatient portal use, incorporate inpatient-centered education materials, and 
improve the portal with functions that add the most value for cancer inpatients.  
CONCLUSIONS  
We found that cancer patients had reached modest levels of portal adoption. 
While portal adoption increased with predisposing and enabling determinants (eg: age, 
sex, marital status, income), active inpatient use increased with need (eg: commute 
residence and high disease severity). While these findings should be cautiously 
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interpreted, the study adds to the growing evidence that patient portals should be further 
addressed for inpatient care. Particularly, the study provides insights for the informatics 
research community and those interested in improving inpatient care and self-
management support through technology.  
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Table 4.1 Sample Baseline Characteristics by Portal Behaviora 
Characteristics Adopters 
(n=2,352) 
Nonadopters 
(n=2,242) 
P 
value 
Active 
Inpatient 
Users 
(n=632) 
Inactive 
Inpatient 
Users 
(n=1,720) 
P 
value 
Age group (years) 
Mean (SD) 
≤44 
45-54 
55-64 
65-74 
75-84 
≥85 
 
62.3 (14.0) 
259 (11.0) 
339 (14.4) 
632 (26.9) 
702 (29.8) 
339 (14.4) 
81 (3.4) 
 
65.4 (14.8) 
191 (8.5) 
281 (12.5) 
480 (21.4) 
652 (29.1) 
454 (20.2) 
184 (8.2) 
 
<.01b 
<.01c 
 
60.2 (14.3) 
82 (13.0) 
106 (16.8) 
185 (29.3)  
166 (26.3) 
80 (12.7) 
13 (2.1) 
 
63.0 (13.8) 
177 (10.3) 
233 (13.5) 
447 (26.0) 
536 (31.2) 
259 (15.1) 
68 (4.0) 
 
<.01b   
<.01c 
Sex 
Female 
Male 
 
1,148 (48.8) 
1,204 (51.2) 
 
1,055 (47.0) 
1,188 (53.0) 
 
.25c 
 
295 (46.7) 
337 (53.3) 
 
852 (49.5) 
869 (50.5) 
.22c 
Race/ethnicity 
African American 
White 
Other 
 
121 (5.2) 
2,120 (91.3) 
80 (3.4) 
 
273 (12.4) 
1847 (84.0) 
78 (3.5) 
<.01c  
18 (2.9) 
575 (91.9) 
33 (5.3) 
 
103 (6.1) 
1,545 (91.2) 
47 (2.8) 
<.01c 
Marital status  
Married 
Single/divorced/wi
dowed 
 
1,786 (75.9) 
566 (24.1) 
 
1,454 (64.9) 
788 (35.1) 
<.01c  
506 (80.1) 
126 (19.9) 
 
1,280 (74.4) 
440 (25.6) 
<.01c 
Employment status 
Employed 
Retired 
Not employed/ 
disabled 
 
739 (37.7) 
836 (42.6) 
386 (19.7) 
 
547 (28.9) 
935 (49.4) 
411 (21.7) 
<.01c  
206 (38.1) 
208 (38.5) 
126 (23.3) 
 
533 (37.5) 
628 (44.2) 
260 (18.3) 
.79c 
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Income  
< FL median  
=> FL median 
 
645 (28.3)  
1,707 (71.7) 
 
803 (37.2)  
1,439 (64.1) 
<.01c  
167 (26.5)  
465 (73.5) 
 
478 (27.8)  
1,242 (72.2) 
.54c 
Health insurance type 
Commercial/self 
Medicare/Medicaid
/other government 
 
1,145 (48.7)  
1,207 (51.3) 
 
815 (36.4)  
1,427 (63.6) 
<.01c  
339 (53.6)  
293 (46.4) 
 
806 (46.9)  
914 (53.1) 
<.01c 
Area of residence 
 Nonlocal  
 Local 
 
521 (22.2) 
1,831 (77.8) 
 
493 (22.0) 
1,749 (78.0) 
.89c  
166 (26.3) 
466 (73.7) 
 
335 (20.6) 
1,365 (79.4) 
<.01c 
Comorbidity d 
 None 
 One or more 
 Comorbidity typee  
CHF 
Peripheral vasc. 
Cerebrovascular 
Chronic pulmonary 
Mild liver disease 
Diabetes mellitus 
Mod./sev. renal  
Mod./sev. liver  
 
1,115 (47.4) 
1,237 (52.6) 
 
145 (6.2) 
322 (13.7) 
165 (7.0) 
262 (11.1) 
432 (18.4) 
392 (16.7) 
196 (8.3) 
121 (5.1) 
 
1,052 (46.9) 
1,190 (53.1) 
 
171 (7.6) 
338 (15.1) 
224 (10.0) 
256 (11.4) 
291 (13.0) 
351 (15.7) 
179 (8.0) 
86 (3.8) 
.58c 
 
 
 
.05c 
.18c 
<.01c 
.77c 
<.01c 
.35c 
.66c 
.03c 
 
289 (45.7) 
343 (54.3) 
 
51 (8.1) 
83 (13.1) 
42 (6.6) 
61 (9.7) 
129 (20.4) 
115 (18.2) 
53 (8.4) 
49 (7.8) 
 
826 (48.0) 
894 (52.0) 
 
94 (5.5) 
239 (13.9) 
123 (7.2) 
201 (11.7) 
303 (17.6) 
277 (16.1) 
143 (8.3) 
72 (4.2) 
.32c 
 
 
 
.02c 
.63c 
.67c 
.16c 
.12c 
.23c 
.96c 
<.01c 
Frequency of 
hospitalizations 
mean (SD) 
 
1.8 (1.5) 
 
1.4 (1.1) 
<.01b  
2.0 (1.7) 
 
1.7 (1.4) 
<.01b 
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Admission type based 
on MSDRG  
Surgical 
Medical 
 
1,504 (63.9) 
848 (36.1) 
 
1,315 (58.7) 
927 (41.3) 
<.01b  
348 (55.1) 
284 (44.9) 
 
1,156 (67.2) 
564 (32.8) 
<.01b 
APRDRG weight 
Mean, (median, 
SD) 
 
2.5 (1.5, 2.9) 
 
2.3 (1.5, 2.3) 
.24b  
3.1 (1.9, 
3.6) 
 
2.3 (1.4, 2.6) 
<.01b 
 
Abbreviations: APRDRG, All Patients Refined Diagnosis Related Group; MSDRG, 
Medicare Severity-Diagnosis Related Group.  
aData are reported as No. (%) for count variables and mean (SD) for continuous 
variables. 
bWilcoxon nonparmetric.   
cPearson χ2 test. 
dComorbidity groups are not mutually exclusive as a patient may have more than 1 
comorbidity diagnosis.   
eComorbidity type was reported for diseases with > 5% of patients. 
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Table 4.2 Logistic Regression Analysis Showing the Predictors of Portal Behaviors 
Factors Characteristics 
Odds Ratio (95% CI)a 
Adoptionb Active Inpatient Usec 
Predisposing 
 
 
Age 
44- 
45-54 
55-64 
65-74 (reference) 
75-84 
85+ 
 
1.42 (1.03, 1.95) 
1.10 (0.82, 1.47) 
1.22 (0.95, 1.57) 
1.00 
0.71 (0.57, 0.87) 
0.36 (0.24, 0.54) 
 
1.89 (1.16, 3.06) 
1.73 (1.10, 2.72) 
1.48 (1.00, 2.19) 
1.00 
1.08 (0.75, 1.56) 
0.77 (0.34, 1.75) 
Sex 
Male (reference) 
Female 
 
1.00 
1.26 (1.10, 1.45) 
 
1.00 
0.97 (0.78, 1.21) 
Race 
White (reference) 
African American 
Others 
 
1.00 
0.34 (0.27, 0.45) 
0.84 (0.58, 1.23) 
 
1.00 
0.51 (0.29, 0.89) 
1.39 (0.82, 2.37) 
Enabling Marital status 
Divorced/single/widowed 
(reference) 
Married 
 
1.00 
 
1.60 (1.37, 1.87) 
 
1.00 
 
1.49 (1.14, 1.94) 
Employment 
Employed (reference) 
Retired 
Not employed/disabled 
 
1.00 
1.04 (0.83, 1.30) 
0.70 (0.57, 0.86) 
 
1.00 
1.04 (0.75, 1.46) 
1.04 (0.77, 1.40) 
  
  
70 
 
 Health insurance type 
Commercial (reference) 
Medicaid/Medicare 
 
1.00 
0.76 (0.61, 0.95) 
 
1.00 
1.07 (0.77, 1.50) 
Income 
< FL median (reference) 
=> FL median  
 
1.00 
1.39 (1.20, 1.60) 
 
1.00 
1.10 (0.87, 1.39) 
Need Area of residence 
Local (reference) 
Nonlocal 
 
1.00 
1.13 (0.96, 1.33) 
 
1.00 
1.34 (1.04, 1.71) 
Comorbidities 
None (reference) 
1+ 
 
1.00 
1.05 (0.91, 1.21) 
 
1.00 
0.97 (0.77, 1.22) 
Frequency of 
hospitalizations 
1.43 (1.33, 1.55) 1.08 (0.99, 1.19) 
MSDRG type d 
Surgical (reference) 
Medical 
 
- 
 
 
1.00 
2.17 (1.68, 2.78) 
APRDRG weight d - 1.13 (1.09, 1.17) 
 
aBold values are statistically significant at P<.05. Odds ratios greater than 1 imply 
increased chance for behavior; less than 1 imply decreased chance for behavior. 
bPredictors for adoption: age, sex, race, marital status, employment status, income, health 
insurance type, and frequency of hospitalizations. 
cPredictors for active inpatient use: age, race, marital status, geographic area of residence, 
APRDRG weight, and MSDRG type.  
dVariables related to the hospital admission were not examined among adopters as the 
adoption behavior was established prior to admission.  
  
 
 
7
1 
Table 4.3 Adverse Events, Postdischarge Care Utilization and Patient Satisfaction Among the portal Behavior Groups 
Measures Outcomes Adopters 
(n=2,352) 
Nonadopters 
(n=2,242) 
P value Active Inpatient 
Users (n=632) 
Inactive 
Inpatient Users 
(n=1,720) 
P 
value 
Patient safety Had an adverse event, No. (%) 40 (1.7) 47 (2.1) .36a 13 (2.1) 27 (1.6) .42a 
Postdischarge 
care utilization 
Emergency visit within 14-days of 
discharge, No. (%) 
272 (11.6) 214 (9.5) .03a 75 (11.9) 197 (11.5) .78a 
30-day unplanned readmission, No. (%) 299 (12.7) 222 (9.9) <.01a 96 (15.2) 203 (11.8) .03a 
Patient 
satisfactionc 
Understand responsibilities for self-health 
management, mean score (SD) 
 
87.6 (19.6) 
 
85.5 (20.1) 
 
.02b 
 
89.1 (18.4) 
 
87.1 (20.0) 
 
.22b 
Understand the purpose for taking each 
medication, mean score (SD) 
 
90.0 (18.8) 
 
87.8 (20.9) 
 
.05b 
 
91.8 (16.0) 
 
89.4 (19.7) 
 
.21b 
Aggregate self-health management 
knowledge score 
84.3 (21.3) 80.0 (23.1) <.01b 87.0 (19.2) 83.3 (21.9) .05b 
Overall rating of the hospital stay, mean 
score (SD) 
95.6 (9.1) 95.3 (10.3) .75b 95.6 (10.5) 95.7 (8.6) .56b 
 
aPearson χ2 test. bWilcoxon nonparametric. cSatisfaction survey was distributed to a random sample of discharges; thus, the sample 
size was as follows: adopters; n=788, nonadopters; n=646, active inpatient users; n=205, and inactive inpatient users; n=577. 
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Table 4.4 Association Between Patient Outcomes and Portal Behaviors: Results From Regression Models  
 
 
Dependent Variablesa 
Independent Variables 
Active Inpatient Users vs Nonadopters Inactive inpatient Users vs Nonadopters 
OR (95% CI) P value OR (95% CI) P value 
[adverse events=yes]  0.76 (0.40, 1.45) .41 0.71 (0.44-1.16) .17 
[emergency visits=yes]  1.28 (0.97, 1.70) .08 1.23 (1.00-1.51) .08 
[readmissions=yes]  1.60 (1.23, 2.08) <.01 1.21 (0.99-1.48) .06 
Dependent Variablesa Beta Coefficient P value Beta Coefficient P value 
Self-health management knowledge 2.18 .07 1.15 .17 
Overall hospital experience 0.16 .83 0.28 .60 
 
aFive regression models were conducted adjusting for age and disease severity. A logistic regression was used for adverse events, 
emergency visits, and readmissions. A linear regression was used for self-health management knowledge and overall hospital 
experience scores. 
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CHAPTER 5 
Manuscript II Femoral and Sciatic Nerve Block Versus Periarticular 
Anesthetic Injection After Total Knee Arthroplasty 
 
ABSTRACT 
Background: Pain is a main concern of patients undergoing total knee arthroplasty 
(TKA). Questions/Purposes: This study compares whether receiving a periarticular 
anesthetic injection (PAI) of ropivacaine, epinephrine, ketorolac, and morphine versus 
femoral nerve block (FNB) combined with single-shot sciatic nerve block (SNB) offers 
better patient outcomes. Patients and Methods: We retrospectively reviewed 
consecutive patients who underwent primary unilateral TKA between March 1, 2013, and 
August 31, 2014 (N=511) and received FNB with SNB versus those who underwent 
TKA between October 1, 2014 and March 31, 2016 (N=479) and received PAI. 
Postoperative outcomes, including pain scores, time to first ambulation, cumulative 
distance walked, in-hospital falls, length of stay, discharge disposition, satisfaction with 
pain control, emergency visits within 14 days, readmissions within 30 days, revisions 
within 90 days, and total cost of hospitalization and 90-day follow-up period, were 
compared. Results: The PAI group had lower pain scores during the first 24 hours after 
TKA, but there was no difference at 48 hours. Patients who received PAI had earlier 
ambulation, longer walking distance, shorter hospital stay, increased discharges home, 
and better satisfaction with pain control.  
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Total cost of hospitalization was less expensive for PAI; on average, each patient who 
had their pain managed using PAI saved $3,539. Insignificant differences were found in 
other variables. Conclusions: PAI is superior in providing early postoperative pain relief, 
improved functional recovery, better patient satisfaction with pain, and lower 
hospitalization cost compared to FNB with single-shot SNB following TKA. 
Level of Evidence: III 
Keywords: Femoral nerve block, Periarticular injections, Pain control, Cost, Total knee 
arthroplasty 
  
INTRODUCTION 
Total knee arthroplasty (TKA), also known as total knee replacement, was the 
third most common operating room procedure (718,000 procedures) in the United States 
in 2011, with an aggregate hospitalization cost of $11.3 billion per year [131]. TKA is 
projected to increase to 3.48 million procedures per year by 2030 due to population aging 
and obesity, contributing to further growth in health care spending [52, 53]. The wide 
diffusion and high cost of this procedure has led clinicians to focus on pain management, 
since severe pain has profound implications on patients’ recovery [107, 108]. 
Accordingly, medical and economic consequences are expected, including 
dissatisfaction, prolonged length of stay (LOS), and increased cost [212]. Thus, effective 
pain control is crucial to improve clinical care and avert unfavorable outcomes. Given the 
importance of pain management, the Joint Commission and the Agency for Healthcare 
Quality and Research introduced standards for organizations to improve their care for 
patients with pain [213, 214].  
  
75 
 
In the last few years, advancements in postoperative pain control moved toward 
multimodal pain management methods, instead of using opioids alone [109]. Of these 
approaches, femoral nerve block (FNB), which is a well-established analgesic to reduce 
pain post-TKA, has been the gold standard [110, 111]. However, many authors reported a 
number of disadvantages, including quadriceps weakness that delays recovery, increased 
risk of neurologic symptoms, falls, opioid abuse, and adverse events [43, 112, 113]. For 
this reason, some clinicians combine sciatic nerve block (SNB) with FNB, instead of 
using FNB alone, in order to improve outcomes early after surgery [114-118]. Yet, the 
advantages of SNB when combined with FNB continue to be debated in the literature 
[119, 120].  
Compared with peripheral nerve block, periarticular anesthetic injection (PAI), a 
concentrated multidrug combination, has been identified as a preferred alternative 
approach for pain management after TKA [121]. Earlier clinical studies were conducted 
to validate the efficacy and safety of different combinations of PAI medication mixture, 
and have reported it to be easier to administer with fewer adverse events [122-124]. 
However, evidence on PAI as a better alternative to other pain management approaches is 
limited, and research is needed to support its efficacy [132-136].  
For several years, our institution had used continuous FNB combined with a 
single-shot SNB and 0.5% ropivacaine for postoperative pain control after TKA. In 
September 2014, the orthopedic practice showed interest in pursuing a change in the pain 
management approach after TKA, and transitioned to use of PAIs. Thus, comparing the 
analgesic effect and other related patient outcomes among patients who used FNB with 
SNB versus PAI was a topic of interest. Outcomes were evaluated postoperatively, 
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including pain scores at 24 and 48 hours after surgery, time to first ambulation, 
cumulative distance walked, patient falls, LOS, discharge disposition, patient satisfaction 
with pain control, and postdischarge measures, including emergency visits within 14 
days, readmissions within 30 days, and revisions within 90 days. We also compared 
detailed cost per type of service and total cost for both the hospitalization episode and the 
90-day follow-up period, separately, for these 2 pain management approaches.  
To our knowledge, there are few reports comparing efficacy, safety, and cost of 
FNB combined with SNB versus PAI in TKA. Our motivation was to examine if the 
latter approach was cost-effective. We found limited research available to inform policy 
on drivers of health care costs in TKA; therefore, results of this study may add value to 
policy-makers and clinicians who are interested in pain management in orthopedic care. 
Because many surgical procedures have migrated to the outpatient setting, many 
orthopedic surgeons are interested in pain control approaches that enable easier and safer 
outpatient TKA that can be provided at lower cost. It is equally important to disseminate 
results of this comparison to patients, which may empower them to take an active role in 
their care and make more informed decisions. 
MATERIALS AND METHODS 
We conducted a retrospective review of patients at least 18 years of age who 
received a primary unilateral TKA. A total of 1,158 TKA patients were screened to 
obtain 990 eligible patients for the study (Figure 5.1). Study outcomes were compared 
between patients who received FNB combined with single-shot SNB between March 1, 
2013, and August 31, 2014, versus patients who received PAI between October 1, 2014, 
and March 31, 2016). Surgeries in September 2014 were excluded to allow the new 
practice to stabilize.  
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The surgical procedure, implants used, and surgery team were consistent in the 2 
periods, minimizing differences in patient and provider factors. Table 1 shows most 
patient characteristics are similar. All patients received a primary general or spinal 
anesthesia by an anesthesiologist using the same preprocedure sedation protocol. 
Combined FNB with SNB or PAI were additional anesthesia given for postoperative pain 
control. For all patients in the FNB group with no notable valgus deformity or 
radiculopathy, the same anesthesiologist administered an indwelling continuous femoral 
catheter supplemented with a single-shot SNB. For patients in the PAI group, the 
anesthetic mixture was administered based on weight, as previously used by Spangehl 
and colleagues [50]. PAI was administered by the performing surgeon, minimizing the 
potential for confounding effects on injection technique. The injection was administered 
by 18-gauge needle as multiple boluses into the periarticular tissue surrounding the knee 
joint prior to site closure, with no additional infusion or injections after site closure. A 30 
cc bolus was injected into the posterior capsule and the remaining boluses were injected 
throughout the anterior knee periarticular and subcutaneous tissues. Postoperative pain 
control was the same for both groups and included use of analgesia, such as morphine, 
acetaminophen, celecoxib, tramadol, and narcotics, administered via oral or intravenous 
means as necessary. 
Patient Characteristics 
Patient demographic and clinical data were obtained from the electronic health 
record (EHR). Comorbidities were counted by the presence of any of the 19 common 
chronic medical conditions included in the Charlson Comorbidity Index, in addition to 
hypertension, stroke, anxiety, and depression in the 12 months prior to hospitalization. 
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Obesity was determined by the body mass index (BMI) documented at time of admission, 
rather than on the International Classification of Diseases code for obesity, which is 
rarely coded. We then classified BMI using weight categories defined by the Centers for 
Disease Control and Prevention. American Society of Anesthesiologists physical status 
classification was used to classify patient disease severity on admission. 
Study Measures 
Pain was assessed postoperatively using a numeric rating scale ranging from 0 (no 
pain) to 10 (worst possible pain) and reported at 24 and 48 hours after surgery. Patient 
functional recovery was measured by time from end of surgery to first walk, and by 
distance walked each day as documented in physical therapy (PT) notes. An attempt was 
made for each patient to receive a PT session on the same day of surgery, with a 
standardized protocol to assist in knee ambulation, standing, and walking. Because some 
patients rejected PT after surgery due to pain or other reasons, the frequency of received 
PT sessions varied between cohorts. Thus, our calculation of distance walked was 
exclusive to the first 3 PT sessions, which was the minimum number of sessions received 
by all patients.  
All patients had TKA on the day of admission, thus, we documented hospital 
LOS, in hours, throughout the hospitalization and from the end of surgery to discharge. 
Patient falls and surgical site infections were obtained from the Quality Management 
Services database for adverse events. Additionally, discharge disposition, emergency 
visits within 14 days after discharge, readmissions within 30 days, and revisions within 
90 days were extracted from the EHR.  
Patient satisfaction was measured by the normal hospital procedure, using the 
validated Hospital Consumer Assessment of Healthcare Providers and Systems 
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(HCAHPS) survey; distributed to a random sample of discharged patients ranging 
between 2 days and 6 weeks after discharge [148]. Thus, only a subset of our patients 
were assessed; 185 (36.2%) from the FNB group and 199 (41.5%) from the PAI group. 
We selected 2 questions to assess satisfaction with pain: “How often was your pain well 
controlled?” and “How often did the hospital staff do everything they could to help you 
with your pain?” Responses were transformed and averaged (never=0, sometimes= 33.3, 
usually=66.6, and always=100), resulting in a 0 to 100 linear-scaled score. One question 
assessed the overall satisfaction with hospital experience: “Using any number from 0 to 
10, where 0 is the worst hospital possible and 10 is the best hospital possible, what 
number would you use to rate this hospital during your stay?” Scores were multiplied by 
10 to create a consistent linear scale.   
Cost data were obtained from our institution’s cost data warehouse [151], which 
applied Medicare reimbursement to professional services, multiplied service line hospital 
charges by Medicare cost report cost-to-charge ratios, and adjusted for inflation with the 
gross domestic product implicit price deflator to create 2016 standardized costs. We 
reported costs separately for the index hospitalization and 90-day follow-up period 
excluding hospitalization, using Berenson-Eggers Type of Service and Uniform Billing-
04 codes to classify the line item data. We further summed cost by type of service, 
grouped in different categories: analgesic approach (i.e., nerve block and the periarticular 
supplies and medications); room and board (i.e., observation and intensive care unit stay); 
operating and recovery room occupation; orthopedic procedure; physical therapy; pain 
medications; laboratory and pathology; supplies; and other costs including blood 
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transfusion, other medications/intravenous fluids, and miscellaneous. Follow-up cost data 
did not include medications obtained from outpatient pharmacies. 
Data Analysis 
Statistical analyses were performed using SAS Version 9.4 (SAS Institute Inc.); 
significance was defined as P<.05 in a 2-tailed test. We performed univariate χ2 tests for 
categorical variables with Fisher's exact test for cell counts <40, and Wilcoxon signed 
rank tests for mean comparisons among continuous variables to account for skewed 
distributions. Cost variables were presented as mean and median cost per patient, 
including SDs and interquartile ranges. We used repeated generalized linear regression 
models to determine if receiving PAI was a predictor for (1) pain scores at 24 hours, (2) 
pain scores at 48 hours, (3) distance walked, (4) postoperative LOS, and (5) total cost of 
index hospitalization. Independent variables in the regression analysis included age, sex, 
race, marital status, BMI, ASA class, and comorbidities. 
In modelling the index hospitalization total cost, we used log-transformed costs. 
For the 90-day follow-up period, we excluded patients with costs exceeding $20,000 not 
related to TKA and patients who were electively readmitted for major surgeries, and 
focused on local patients (n=263 and n=278 for FNB and PAI patients, respectively), who 
were more likely to have follow-up services performed at our institution. This study was 
approved by the institutional review board, and no external source of funding was 
obtained. 
RESULTS 
Of the total population, more than 99% of patients had their TKA as an elective 
procedure. The majority were white (91.3%), married (74.0%), women (61.5%), living 
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locally in Jacksonville, Florida (57.1%), with a mean age of 68.0 years (SD 9.4 years). 
With regards to comorbidities, 55.3% did not have any comorbid conditions reported in 
the last 12 months, and among those who did have comorbidity, 25.7% were 
hypertensive, 10.2% were diabetic, and 6.5% suffered from cancer. Patient demographic 
and clinical characteristics were similar in both FNB and PAI groups, except for ASA 
class that was included as a covariate in regression analyses. Baseline characteristics are 
reported in Table 5.1. 
Postoperative Outcomes 
Analgesic Efficacy: Patient pain scores at 24 hours after surgery were significantly lower 
in the PAI group (2.2 [1.5]) versus the FNB group (2.8 [1.7]; P< .01). No significant 
differences were reported between the groups in the next postoperative day (24-48 
hours). Statistical tests were not performed for 48 and thereafter, due to the limited 
number of patients remaining to be hospitalized (Table 5.2). 
Functional Recovery: Patients in the PAI group experienced earlier ambulation, where 
33 (6.8%) walked on the day of surgery compared to 4 (0.8%) in the FNB group (P<.01). 
Distance walked was also higher among the PAI group (86.5 meters [82.2]) than the FNB 
group (48.0 meters [67.0]; P<.01) in the first 3 PT sessions. We also noted fewer patient 
falls among the PAI group, but differences were not statistically significant (P>.05) 
(Table 5.2).  
Other Outcomes: We found patients in the PAI group had a significant decrease in 
postoperative LOS by about 14.4 hours, from 71.2 hours with FNB to 56.8 hours with 
PAI (P<.01). In addition, 382 (79.3%) patients who received PAI were able to be 
discharged home rather than to other care or rehabilitation facilities, compared with 248 
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(48.2%) who received FNB. We found 4 PAI cases with surgical site infections, while 
none were seen among the FNB patients (P=.05), but no significant differences were 
detected in emergency visits, readmissions, and revisions (Table 5.2).  
Patient Satisfaction 
Patient satisfaction with pain control was significantly higher among patients in 
the PAI group compared to FNB (P<.01), but no differences were observed in the overall 
hospital experience (Table 5.3). 
Cost 
The total standardized cost of hospitalization was 22.8% more expensive for pain 
management using FNB combined with single-shot SNB compared to PAI ($15,542 
[$2,464] vs $12,002 [$3,079]; P<.01). Differences in cost per type of service between the 
2 pain management approaches were significant in almost all categories (Table 5.4 and 
Figure 5.2). However, the total cost throughout the 90-day period after discharge was 
similar for the 2 pain management approaches (Table 5.5).  
PAI as a Predictor for Study Outcomes 
As a secondary analysis, we applied several linear regression models to test if PAI 
(independent variable) was a predictor for selected study outcomes, including pain scores 
at 24 and 48 hours, time to first ambulation, distance walked, postoperative LOS, and 
total cost of hospitalization after adjusting for patient demographic and clinical factors. 
Our results indicated that receiving PAI was a significant predictor for lower pain at the 
first 24 hours postoperatively (β=-0.55, P<.01), earlier ambulation (β=-8.88, P<.01), 
further distance walked (β=27.42, P<.01), shorter postoperative LOS (β=-13.72, P<.01), 
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and lower hospitalization cost (β=-0.26, P<.01; $4,040 savings). Regression model 
results are presented in Table 5.6. 
DISCUSSION 
Both FNBs with single-shot SNB and PAIs have been widely used to alleviate 
postoperative pain after TKA. Our retrospective study was conducted to determine 
whether using PAI had advantages on patient outcomes compared to FNB with SNB in 
the immediate postoperative time period. Based on study results, patients who received 
PAI reported lower pain scores at 24 hours after TKA and were more satisfied with pain 
control. PAI patients were able to ambulate earlier, walk further, and be discharged 
sooner, and to home rather than a rehabilitation center. In addition, findings from 
adjusted regression models provided further evidence of the positive association between 
using PAI and these patient outcomes. 
A likely key to patient recovery is controlling postoperative pain [215]. The 
psychological factor of feeling better after a major surgery like TKA, known to be a 
painful procedure, could increase patient motivation to engage in rehabilitation and 
recovery efforts [216, 217]. As the PT protocol in our institution began on the day of 
surgery, patients in the PAI group who experienced less pain were more able to initiate 
therapy immediately after TKA. In return, earlier mobility and improved functional 
recovery were observed among this cohort. Consistent with our results, other researchers 
have reported positive association of PAI with reduced pain and effective motor function 
compared to other pain management approaches [45, 218-220]. Toftdahl et al [127] 
compared early functional benefits of PAI compared to FNB and reported more patients 
in the PAI group could walk greater than 3 meters on the day of surgery. In contrast, 
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Tanikawa et al [133] found that FNB with SNB was more effective than PAI in reducing 
pain within 3 hours after TKA, but less effective than PAI at 24 hours. The authors 
speculate that PAI may have had a longer acting time because, while SNB was performed 
prior to surgery, PAI was administered during surgery and may not have taken immediate 
effect. Jian et al’s [221] meta-analysis results indicated equivalence of analgesic effect 
between SNB and PAI groups at 24 hours. Chaubey et al [222] determined that FNB 
provided better pain relief but reduced range of motion, while Carli et al [223] concluded 
that FNB provided improved recovery initially and at 6 weeks. Beebe et al [41] reported 
that FNB did not prevent early ambulation, and several studies agreed that FNB and PAI 
had comparable pain intensity and effect on mobilization [50, 224-226]. 
Contrary to common concerns, occurrence of inpatient falls did not differ 
significantly between the 2 groups, although 6 patients (1.2%) in the FNB group fell after 
TKA compared with 2 in the PAI group (0.4%). Similarly in another study, 3 of 79 
patients (4%) with FNB combined with SNB fell after TKA compared with 1 fall in 81 
patients (1%) in the PAI group, but differences were not statistically significant [50]. We 
previously reported a higher number of surgical site infections in the PAI group; these 
patients were more likely to be readmitted (2 of 4), have revisions (3 of 4), and were 
more expensive cases (above the average mean), both during the hospitalization and 
follow-up. Iwakiri et al [227] studied 106 TKA patients who received PAI with or 
without morphine and did not detect any infection cases. Further reports found no 
differences in the rate of adverse events between FNB and PAI groups, and none of the 
adverse events were directly related to analgesic approach [121, 129, 133, 219, 228]. 
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In terms of hospital LOS, we found a significant decrease in duration of stay 
among patients in the PAI group. In an earlier report by Dalury [229], the mean hospital 
LOS among patients who received PAI was 1.2 days, with most patients being discharged 
home within 24 hours, and all by 48 hours. Similarly, Broome and Burnikel [230] found a 
decrease in LOS from 60 hours to 53 hours when PAI was used compared to FNB. Yet, 
contradicting results in the literature do exist, indicating no differences between FNB 
with or without SNB or PAI in reducing hospital LOS [133, 136, 223, 225, 231]. 
 As might be anticipated from the low pain scores reported in the PAI group, 
patients also reported higher satisfaction with pain control compared to patients who 
received FNB. However, while PAI patients had improved pain experience, no significant 
differences were noted in overall satisfaction. Our patient satisfaction metrics were 
collected after discharge, and so, are subject to recall bias; yet, it was interesting to find a 
remarkably high satisfaction with pain control in the postdischarge period in both groups. 
Apfelbaum et al [232] reported more patients experience pain after discharge than before, 
and Lostak et al [233] demonstrated that the rate of satisfaction is high shortly after 
surgery, but declines gradually thereafter. According to the literature, patient 
dissatisfaction with pain after TKA is very common, ranging from 7.5% to 28.3%, while 
our PAI group only had a 7.3% dissatisfaction rate [234, 235]. With many research 
efforts conducted to seek early pain control and improved patient satisfaction, using PAI 
continues to be an effective option [123]. 
Our study found evidence of significant savings when pain was managed using 
PAI (P<.01). The standardized cost of analgesic approach materials (i.e., medications and 
supplies) was 2.6 times higher for FNB compared to PAI; ($1,900 [$664] vs $713 [$150], 
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respectively). In addition, the cost of pain medications was 1.4 times higher for FNB 
patients, suggesting that using PAI may be possible to decrease the consumption of 
opioids among patients. However, decisions about cost-effectiveness need to be based on 
the entire cost of the episode rather than type of services; thus, our study concludes that 
each patient who had their pain managed using PAI of ropivacaine, epinephrine, 
ketorolac, and morphine saved approximately $3,539 on their total TKA hospitalization 
(P<.01). This lower total cost is not strictly due to earlier discharges, as our calculation of 
cost per type of service showed lower costs across majority of services. We observed no 
significant differences the total cost of the 90-day follow-up period after discharge, 
suggesting that savings from post-surgical pain management approach during the 
hospitalization episode are not offset with higher follow-up costs. 
Among other studies that used nonstandardized costing methods, the cost of PAI 
with liposomal bupivacaine was $285, compared to the cost of FNB, which was $640 
[230]. Dalury et al [229] estimated the cost of PAI with ropivacaine, epinephrine, 
ketorolac, and clonidine as $46, and Corman et al [236] estimated cost of PAI with 
bupivacaine, morphine, methylprednisolone, and cefuroxime as low as $16. The latter 
study also estimated the cost of PAI with bupivacaine liposome as $319 and of 
continuous peripheral nerve block with ropivacaine as $757.  
It is important to point out that the mixed conclusions regarding PAI efficacy and 
cost may be driven by differences in PAI mixture and methodology [212, 237]. Currently, 
little scientific data exist to define guidelines for the most effective medication 
combination or pain management protocol [122, 228, 229, 238, 239]. Therefore, use of 
different PAI medication combinations (ie, medication type and volume) adds to the 
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variability in cost across studies. The injection administration technique may also vary 
among surgeons, and few studies provide clear descriptions of their administration 
technique. Broome [49] demonstrated that using a small needle, such as 22-gauge instead 
of 18-gauge, and infiltrating small amounts in a large number of locations provides better 
efficacy. Dalury [229] recommended the use of control syringes, which allow for 
aspiration before injection and are more comfortable for a surgeon’s hand. More studies 
may be needed to identify the best PAI approach before final conclusions are made on 
cost-effective pain management approaches.  
Our study is limited by a retrospective, single-institution design using consecutive 
patients at 2 exclusive, yet consecutive, time periods. The pain control protocol transition 
from FNB with SNB to PAI was the only change introduced in the study time periods, 
patient cohorts were clinically similar, and the same surgeons performed the operations. 
Furthermore, our EHR did not contain detailed information on the progress of 
rehabilitation; thus, our mobility measures were limited to the in-hospital phase, yet these 
data are important to report as short-term mobility indicators. Additionally, patient self-
reported pain scores often have great disparity due to variability in tolerance of pain. Still, 
electronically-documented pain scores in the EHR, a major study asset, ensured accuracy, 
synchronous collection and easy data retrieval for this large patient cohort. Conclusions 
regarding patient satisfaction with pain control are limited due to the smaller sample size, 
a consequence of the randomized nature of HCAHPS collection, but no other satisfaction 
measures were readily available. While regression analyses were applied to demonstrate 
associations adjusted for potential covariates, causation cannot be proven. Finally, our 
cost analysis relied upon administrative claims data from our institution and we were 
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unaware about post-care consumed elsewhere. Our calculation of cost in the follow-up 
period was limited to local patients, who were more likely to have follow-up services 
performed at our institution. Despite these limitations, the study uncovered differences 
between 2 well established pain management approaches used for TKA in nearly 1,000 
patients. Our unique ability to combine patient clinical data from medical records with 
administration billing data, categorizing all line item services according to type into 
related categories, and then applying cost standardization instead of nominal charges, 
provides valuable information for policy makers and clinicians who are interested in 
measuring value in health care. To our knowledge, this is the first study to examine 
detailed cost per services between PAI and FNB with single-shot SNB for primary TKA. 
CONCLUSIONS  
The replacement of FNB with PAI led to improvements in hospital value metrics, 
including early pain relief, recovery, LOS, patient satisfaction with pain, and total 
hospitalization cost. Our findings provide valuable insight for clinicians and 
policymakers to determine the most efficient and cost-effective pain management 
approach after TKA, and can promote evidence-based clinical policy for cost-effective 
pain management in orthopedic care. It is suggested to improve and expand the use of 
PAI, but with caution in relation to possible infections or increased postdischarge cost. 
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Figure 5.1 Flow Diagram of Patient Exclusions and Eligibility.  
FNB indicates femoral nerve block; LOS, length of stay; NB, nerve block; PAI, 
periarticular anesthetic injection; SNB, sciatic nerve block; and TKA, total knee 
arthroplasty.  
*Exclusion criteria in the 90-day follow-up period are not mutually exclusive.  
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Figure 5.2 Comparison of Hospitalization Cost Per Service Between FNB and PAI.  
FNB indicates femoral nerve block; OR, operating room; and PAI, periarticular anesthetic injection. 
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Table 5.1 Sample Baseline Characteristics By Pain Management Approach 
Characteristics Total Sample, 
No. (%) N=990 
FNB, No. (%) 
n=511 
PAI, No. (%) 
n=479 
P Value 
Age, y     
Mean (SD) 68.0 (9.4) 68.2 (9.3) 67.7 (9.6) 0.52a 
≤ 54 67 (6.8) 35 (6.8) 32 (6.7) 0.77b 
55-64 285 (28.8) 140 (27.4) 145 (30.3)  
65-74 402 (40.6) 214 (41.9) 188 (39.2)  
≥ 75 236 (23.8) 122 (23.9) 114 (23.8)  
BMI     
Normal (18.5-24.9)  141 (14.2) 79 (15.4) 62 (12.9) 0.46b 
Overweight (25.0-29.9) 315 (31.8) 166 (32.4) 149 (31.1)  
Obese (≥ 30.0) 534 (54.0) 266 (52.2) 268 (56.0)  
Sex     
Female 609 (61.5) 328 (64.2) 281 (58.7) 0.07b 
Male 381 (38.5) 183 (35.8) 198 (41.3)  
Race     
African American 58 (6.0) 25 (5.0) 33 (7.0) 0.37b 
White 885 (89.3) 456 (89.2) 429 (89.5)  
Other 47 (4.7) 30 (5.8) 17 (3.5)  
Marital status     
Married 733 (74.0) 377 (73.8) 356 (74.3) 0.85b 
Single/divorced/widow 257 (26.0) 134 (26.2) 123 (25.7)  
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Employment status 
    
Employed 240 (30.7) 112 (28.6) 128 (32.8) 0.25b 
Retired 422 (54.0) 223 (56.9) 199 (51.0)  
Not employed/disabled 120 (15.3) 57 (14.5) 63 (16.2)  
Area of residence     
Local (Jax area) 565 (57.1) 276 (54.0) 289 (60.3) 0.13b 
Regional (120-mile) 276 (27.9) 151 (29.5) 125 (26.1)  
Distant 
(national/international) 
149 (15.1) 84 (16.4) 65 (13.6)  
Payer type     
Nongovernment 
insurance 
353 (35.7) 171 (33.5) 182 (38.0) 0.14b 
Government insurance 637 (64.3) 340 (66.5) 297 (62.0)  
Tobacco use     
Ever (current or former) 469 (47.4) 229 (44.8) 240 (50.1) 0.10b 
Never 521 (52.6) 282 (55.2) 239 (49.9)  
ASA scorec     
Normal healthy person 10 (1.0) 7 (1.4) 3 (0.6) 0.02b 
Mild systematic disease 464 (46.9) 219 (42.9) 245 (51.1)  
Severe systematic dis. 516 (52.1) 285 (55.8) 231 (48.2)  
CCI     
Weighted, mean (SD) 0.6 (1.2) 0.7 (1.2) 0.6 (1.1) 0.22a 
Age-weighted, mean 
(SD) 
3.0 (1.6) 3.1 (1.6) 2.9 (1.6) 0.19a 
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Comorbidityd     
0 547 (55.3) 270 (52.8) 277 (57.8) 0.16b 
1-2 359 (36.3) 190 (37.2) 169 (35.3)  
≥ 3 84 (8.5) 51 (10.0) 33 (6.9)  
Top comorbid conditionse     
Hypertension 254 (25.7) 152 (29.7) 102 (21.3) <0.01b 
Diabetes 101 (10.2) 56 (11.0) 45 (9.4) 0.46b 
Peripheral vascular  65 (6.6) 42 (8.2) 23 (4.8) 0.04b 
Cancer  64 (6.5) 33 (6.5) 31 (6.5) >0.99b 
Chronic pulmonary  60 (6.1) 35 (6.8) 25 (5.2) 0.30b 
Anxiety/depression 43 (4.3) 17 (3.3) 26 (5.4) 0.12b 
Elective admission      
Elective 987 (99.7) 509 (99.6) 478 (99.8) 0.60b 
Surgery time, m     
Mean (SD) 96.1 (21.5) 96.0 (22.8) 96.2 (20.3) 0.84b 
Anesthesia time, m     
       Mean (SD) 150.2 (25.7) 149.9 (26.9) 150.5 (24.3) 0.62b 
 
Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index; 
CCI, Charlson Comorbidity Index; FNB, femoral nerve block; PAI, periarticular 
anesthetic injection. 
aWilcoxon signed rank test 
bUnivariate χ2 test 
cASA score  
dComorbidity includes the number of conditions in CCI in addition to: 
depression/anxiety, hypertension, and stroke 
eComorbid conditions are not mutually exclusive as a patient may have more than 1 
comorbidity diagnosis 
  
  
94 
 
Table 5.2 Comparison of Outcomes Between FNB and PAI Groups 
Outcomes 
FNB 
(n=511) 
PAI 
(n=479) 
P 
Value 
Pain scores, mean (SD)    
At 24 hours 2.8 (1.7)  2.2 (1.5) <0.01a 
At 48 hours 3.1 (1.6) 3.1 (1.7) 0.68b 
Functional recovery    
PT sessions received by patients, mean (SD) 3.5 (1.4) 4.4 (1.6) <0.01a 
Median (IQR) 
 
Range 
4.0 (3.0, 
4.0) 
(3.0-9.0) 
4.0 (3.0, 
5.0) 
(3.0-15.0) 
 
Walked during first 24 h postoperatively, No. (%) 4 (0.8) 33 (6.8) <0.01b 
Walked during 24-48 h postoperatively, No. (%) 494 (96.7) 477 (99.6) 0.01c 
Distance walked in first 3 PT sessions, mean (SD), m 48.0 (67.0) 86.5 (82.2) <0.01a 
Time to first ambulation, mean (SD), h 31.3 (13.3) 22.3 (9.0) <0.01a 
In-hospital falls, No. (%) 6 (1.2) 2 (0.4) 0.29b 
Surgical site infections 0 (0.0) 4 (0.8) 0.05b 
Length of stay    
Time from admission to surgery, mean (SD), h 3.6 (1.2) 3.8 (4.7) 0.40a 
Time from admission to discharge 
mean (SD), h  
mean (SD), d 
 
76.3 (15.9) 
2.9 (0.7) 
 
62.2 (20.7) 
2.3 (0.9) 
 
<0.01a 
<0.01a 
Time from end of surgery to discharge  
mean (SD), h  
mean (SD), d 
 
71.2 (15.9) 
2.9 (0.7) 
 
56.8 (20.0) 
2.3 (0.8) 
 
<0.01a 
<0.01a 
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Discharge dispositiond    
Home/home health, No. (%) 248 (48.2) 382 (79.3) <0.01c 
Other facility, No. (%) 266 (51.8) 100 (20.7) <0.01c 
Postdischarge     
Emergency visit within 14 days, No. (%) 19 (3.7) 19 (3.9) 0.87b 
Readmission within 30 days, No. (%) 9 (1.8) 10 (2.1) 0.82b 
Revision within 90 days, No. (%) 1 (0.2) 3 (0.6) 0.36b 
 
Abbreviations: FNB, femoral nerve block; PAI, periarticular anesthetic injection; POD, 
postoperative day; PT, physical therapy. 
aWilcoxon signed rank test 
bFisher exact test  
cUnivariate χ2 test  
dInpatient mortality was 0 in both groups  
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Table 5.3 Comparison of Patient Satisfaction Between FNB and PAI Groups 
Questionsa 
FNB 
(n=158)b 
PAI 
(n=199)b 
P Value 
How often was your pain well controlled?  88.4 (18.4) 92.7 (16.8) 0.01c 
How often did the hospital staff do everything 
they could to help you with your pain?  
95.3 (12.8) 98.5 (8.5) <0.01c 
Your overall rating of the hospital stay 96.6 (8.1) 97.4 (6.5) 0.54c 
 
Abbreviations: FNB, femoral nerve block; PAI, periarticular anesthetic injection. 
aSatisfaction survey was distributed to a random sample of discharges (FNB=158 
patients, PAI=199 patients). 
bValues expressed as mean (SD). 
cWilcoxon signed rank test. 
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Table 5.4 Comparison of Hospitalization Cost Between FNB and PAI Groups 
Servicesa Groups Mean (SD) Median IQR P 
Analgesic 
approach  
FNB 2,273.9 (673.5) 2,546.3 1,717.2, 2,674.2 <0.01b 
PAI 1,087.6 (177.9) 1,063.7 968.0, 1,188.5  
Pain 
medications 
FNB 238.0 (148.3) 235.0 107.0, 316.9 <0.01b 
PAI 160.3 (103.3) 138.7 79.3, 208.9  
Room and 
board  
FNB 3,820.3 (1,192.9) 3,972.6 3,069.7, 4,153.2 <0.01b 
PAI 2,739.5 (1,277.2) 2,437.7 1,805.7, 3,340.6  
OR 
and recovery  
FNB 3,226.8 (556.5) 3,189.5 2,865.4, 3,488.8 <0.01b 
PAI 3,037.9 (497.4) 2,996.3 2,705.3, 3,285.8  
Orthopedic 
procedure 
FNB 1,901.0 (790.2) 1,400.3 1,400.3, 1,624.4 0.02b 
PAI 1,564.0 (345.1) 1,400.3 1,400.3, 1,624.4  
Supplies FNB 2,040.5 (718.9) 2,070.6 1,599.6, 2,316.7 0.09b 
PAI 2,035.6 (875.1) 2,041.9 1,577.5, 2,256.4  
Physical 
therapy  
FNB 622.9 (172.7) 601.1 518.9, 686.7 <0.01b 
PAI 496.9 (177.7) 468.2 386.4, 573.5  
Other costs  FNB 1,792.4 (582.5) 1,634.2 1,497.4, 1,863.0 <0.01b 
PAI 1,255.7 (1,519.0) 1,025.1 884.6, 1,249.3  
Total cost in 
2016 $US 
FNB 15,541.9 (2,463.7) 15,090.3 14,202.0, 16,415.9 <0.01b 
PAI 12,002.8 (3,079.5) 11,375.9 10,455.0, 12,559.7  
 
Abbreviations: FNB, femoral nerve block; IQR, interquartile range; OR, operating room; 
PAI, periarticular anesthetic injection; TKA, total knee arthroplasty. 
a Categories of services: (1) analgesic approach, including nerve block and periarticular 
supplies and medications; (2) pain medications; (3) room and board, including 
observation and intensive care unit room and board; (4) OR and recovery; (5) orthopedic 
procedure; (6) supplies, including prostheses and nonprosthesis; (7) physical therapy; (8) 
laboratory and pathology; and (9) other costs, including blood transfusion, other 
medications/intravenous fluids, and miscellaneous. bWilcoxon signed rank test. 
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Table 5.5 Comparison of 90-day Postdischargea Care Costs Between FNB and PAI  
Servicesb Group Mean (SD) Median Ranged P  
Evaluation & manag. FNB 204.2 (342.2) 73.4 (0.0-2,725.7) 0.52c 
PAI 220.7 (348.0) 90.2 (0.0-2,522.7) 
Room and board 
  
FNB 137.7 (795.4) 0.0 (0.0-7,854.9) 0.64c 
PAI 173.7 (862.6) 0.0 (0.0-6,828.5) 
OR and recovery  FNB 73.1 (423.7) 0.0 (0.0-5,901.4) 0.48c 
PAI 57.9 (329.1) 0.0 (0.0-3,025.6) 
Orthopedic procedure FNB 15.3 (133.2) 0.0 (0.0-1,961.2) 0.01c 
PAI 26.4 (177.9) 0.0 (0.0-2,584.5) 
Pain medications  FNB 45.5 (211.1) 0.0 (0.0-2,284.1) 0.21c 
PAI 39.7 (247.2) 0.0 (0.0-3,550.3) 
Other pharma. FNB 85.7 (726.7) 0.0 (0.0-10,992.6) 0.44c 
PAI 62.5 (442.6) 0.0 (0.0-5,775.9) 
Lab and Pathology  FNB 23.2 (93.3) 0.0 (0.0-695.2) 0.42c 
PAI 29.3 (102.4) 0.0 (0.0-719.9) 
Supplies FNB 14.0 (59.2) 0.0 (0.0-404.2) 0.47c 
PAI 25.4 (141.3) 0.0 (0.0-1,457.5) 
Physical therapy  FNB 13.9 (77.1) 0.0 (0.0-795.5) 0.96c 
PAI 12.1 (62.0) 0.0 (0.0-518.9) 
Other costs  FNB 459.7 (897.5) 122.8 (0.0-7,921.8) 0.21c 
PAI 584.1 (1,337.4) 148.4 (0.0-15,214.1) 
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Total cost inflated to 
2016 US dollars  
FNB 1,078.1 (2,314.5) 258.5 (0.0-16,302.2) 0.39c 
PAI 1,236.1 (2,513.1) 317.9 (0.0-16,868.5) 
 
Abbreviations: FNB, femoral nerve block; PAI, periarticular anesthetic injection; OR, 
operating room. 
a90-day postdischarge cost was calculated for 263 FNB patients and 278 PAI patients. 
Refer to the list of exclusion criteria in Figure 1. 
bCategories of services: (1) evaluation and management; (2) room and board, including 
observation and intensive care unit room and board; (3) OR and recovery; (4) orthopedic 
procedure; (5) pain medications; (6) other pharmaceuticals, including intravenous; (7) 
laboratory and pathology; (8) supplies, including prostheses and nonprosthesis; (9) 
physical therapy; and (10) other costs, including blood transfusion and miscellaneous. 
cWilcoxon signed rank test. 
dInterquartile range was 0.00-0.00 for most categories; thus, range was reported to 
provide better information about spread of cost. IQR for total cost was [FNB (51.1, 
1,072) and PAI (39.4, 1,245.4)]. 
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Table 5.6 Linear Regression Analysis of Predictors of Selected Outcomes in TKA 
Dependent Variables Pain Scores 
(at 24 hours) 
Pain Scores 
(at 48 hours) 
Time to First 
Ambulationa 
Distance Walkedb Postoperative LOSc Total Cost Index 
(Transformed Log) 
β P Value β P Value β P Value β P Value β P Value β P Value 
Intercept 2.08 <0.01 2.24 <0.01 29.05 <0.01 93.85 <0.01 67.37 <0.01 9.60 <0.01 
Approach              
FNB (reference)             
PAI -0.55 <0.01 0.08 0.38 -8.86 <0.01 34.48 <0.01 -13.73 <0.01 -0.26 <0.01 
Age             
≤ 54 0.93 <0.01 1.01 <0.01 -0.80 0.61 11.61 0.21 -3.42 0.15 0.05 0.03 
55-64 0.26 0.03 0.39 <0.01 -0.48 0.59 12.64 0.02 -2.55 0.06 0.02 0.20 
65-74 (reference)             
≥ 75 -0.37 <0.01 -0.36 <0.01 1.44 0.14 -11.49 0.05 3.81 0.01 -0.02 0.18 
Sex              
Male (reference)             
Female 0.44 <0.01 0.47 <0.01 1.70 0.02 -41.82 <0.01 5.43 <0.01 0.02 0.12 
Race              
White (reference)             
African American -0.02 0.93 0.04 0.85 -1.52 0.34 -0.38 0.96 -0.29 0.90 0.04 0.10 
Other -0.10 0.74 -0.54 0.08 -1.28 0.56 51.64 <0.01 -2.65 0.45 -0.05 0.15 
  
 
 
1
0
1 
Marital Status             
Not married (reference)              
Married  0.03 0.79 0.09 0.44 -1.11 0.20 0.22 0.96 -3.62 <0.01 - - 
Obesity (BMI ≥ 30 kg/m2)             
No (reference)             
Yes 0.18 0.08 0.13 0.21 0.75 0.33 -20.77 <0.01 0.95 0.41 0.02 0.08 
Comorbidity              
0 (reference)             
1-2 0.20 0.05 0.24 0.02 0.53 0.50 -3.02 0.53 1.80 0.12 -0.03 0.65 
≥ 3 0.45 0.01 0.44 0.01 -0.34 0.80 -11.82 0.16 3.41 0.10 0.05 0.02 
ASA              
Normal or mild 
(reference) 
            
Severe 0.26 0.01 0.38 <0.01 2.75 <0.01 -15.63 <0.01 2.78 0.02 0.04 <.01 
 
Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index; FNB, femoral nerve block; LOS, length of stay; 
PAI, periarticular anesthetic injection; TKA, total knee arthroplasty. 
aHours from end of surgery to first walk. 
bMeters walked in first 3 physical therapy sessions after surgery. 
cHours from end of surgery to discharge.
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